Guilin Tang, M.D., Ph.D., FACMG

Peer-Reviewed Articles

1. Bataller A, Kantarjian H, Bazinet A, Kadia T, Daver N, DiNardo CD, Borthakur G, Loghavi S, Patel K, Tang G, Sasaki K, Short NJ, Yilmaz M, Issa GC, Alvarado Y, Montalban-Bravo G, Maiti A, Abbas HA, Takahashi K, Pierce S, Jabbour E, Garcia-Manero G, Ravandi F. Outcomes and genetic dynamics of acute myeloid leukemia at first relapse. Haematologica 109(11):3543-3556, 2024. e-Pub 2024. PMID: 38695144.
2. Shen Q, Jabbour EJ, Tang G, Fang H, Wang W, Short NJ, You MJ, Medeiros LJ, Hu S. Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia. Am J Hematol 99(11):2244-2248, 2024. e-Pub 2024. PMID: 39152741.
3. Pasvolsky O, Marcoux C, Milton DR, Pal B, Tanner MR, Bashir Q, Srour S, Lee J, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Kebriaei P, Becnel MR, Lee HC, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation. Blood Cancer J 14(1):189, 2024. e-Pub 2024. PMID: 39482325.
4. Marcoux C, Pasvolsky O, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Lee HC, Patel KK, Kebriaei P, Ahmed A, Aljawai Y, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma with Deletion 17p. Transplant Cell Ther, 2024. e-Pub 2024. PMID: 39448031.
5. Xu J, Kim DH, Wang W, Li S, Lin P, Tang G, Konoplev S, Qiu L, Fang H, Garces S, Leventaki V, E S, Medeiros LJ, Wang SA. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. Am J Clin Pathol. e-Pub 2024. PMID: 39244687.
6. E S, Xu J, Wang SA, Tang G, Jabbour EJ, Li S, You MJ, Medeiros LJ, Yin CC. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia. Am J Clin Pathol. e-Pub 2024. PMID: 39235991.
7. Kim DH, Wang SA, Wang W, Tang G, Li S, Yin CC, Lin P, Konopleva M, You MJ, Miranda RN, Wang X, Wei Q, Medeiros LJ, Xu J. Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis. Haematologica 109(8):2711-2715, 2024. e-Pub 2024. PMID: 38546693.
8. Halper-Stromberg E, Stinnett V, Morsberger L, Pallavajjala A, Levis MJ, DeZern AE, Lei M, Phan B, Xian RR, Gocke CD, Tang G, Zou YS. 1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival. Exp Hematol Oncol 13(1):73, 2024. e-Pub 2024. PMID: 39090734.
9. Pasvolsky O, Marcoux C, Dai J, Milton DR, Tanner MR, Syed N, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Lee HC, Gaballa MR, Patel KK, Kebriaei P, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades. Transplant Cell Ther 30(8):772.e1-772.e11, 2024. e-Pub 2024. PMID: 38852784.
10. Loghavi S, Wei Q, Ravandi F, Quesada AE, Routbort MJ, Hu S, Toruner GA, Wang SA, Wang W, Miranda RN, Li S, Xu J, DiNardo CD, Daver N, Kadia TM, Issa GC, Kantarjian HM, Medeiros LJ, Tang G. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. Am J Hematol. e-Pub 2024. PMID: 39016111.
11. Pasvolsky O, Wang Z, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Kebriaei P, Aljawai Y, Khan HN, Lee HC, Ye C, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation. Blood Cancer J 14(1):82, 2024. e-Pub 2024. PMID: 38760362.
12. Zou YS, Klausner M, Ghabrial J, Stinnett V, Long P, Morsberger L, Murry JB, Beierl K, Gocke CD, Xian RR, Toomer KH, Ye JC, Orlowski RZ, Huff CA, Ali SA, Imus PH, Gocke CB, Tang G. A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping. Blood Cancer J 14(1):78, 2024. e-Pub 2024. PMID: 38702349.
13. Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, Vaughn NR, Baran N, Deng Q, Matthews J, Gunaratne PH, Antunes DA, Ekmekcioglu S, Sasaki K, Garcia MB, Cuglievan B, Hao D, Daver N, Green MR, Konopleva M, Futreal A, Post SM, Abbas HA. Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nat Commun 15(1):1821, 2024. e-Pub 2024. PMID: 38418901.
14. Li S, Tang G, Jain P, Lin P, Xu J, Miranda RN, Cheng J, Yin CC, You MJ, Wang ML, Medeiros LJ. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?. Mod Pathol 37(2):100405, 2024. e-Pub 2024. PMID: 38104893.
15. Nahmod KA, Tang G, Li S, Torres-Cabala C, Xu J. Acquisition of TP63 Rearrangement in Large Cell Transformation of Mycosis Fungoides. EJHaem 5(1):264-265, 2024. e-Pub 2024. PMID: 38406547.
16. Pasvolsky O, Ghanem S, Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Khan HN, Kebriaei P, Lee HC, Patel KK, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. Blood Cancer J 14(1):4, 2024. e-Pub 2024. PMID: 38199987.
17. Bataller A, Abuasab T, McCall D, Wang W, Cuglievan B, Issa GC, Jabbour E, Short N, DiNardo CD, Tang G, Garcia-Manero G, Kantarjian HM, Sasaki K. Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineage-directed therapies. Haematologica 109(1):293-297, 2024. e-Pub 2024. PMID: 37646654.
18. Diks J, Tang Z, Altan M, Anderson S, Chen H, Rashid A, Yang RK, Routbort MJ, Patel KP, Toruner GA, Medeiros LJ, Tang G, Luthra R, Roy-Chowdhuri S. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization. Cancer Cytopathol 132(1):41-49, 2024. e-Pub 2024. PMID: 37747438.
19. Tang G, Wu Y, Lin P, Toruner GA, Hu S, Li S, Qazilbash MH, Orlowski RZ, Ye C, Xu J, Nahmod KA, Medeiros LJ, Tang Z. Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells. Cancers (Basel) 15(23), 2023. e-Pub 2023. PMID: 38067393.
20. Esplen HP, Yang RK, Kalia A, Tang Z, Tang G, Medeiros LJ, Toruner GA. Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma. Life (Basel) 13(11), 2023. e-Pub 2023. PMID: 38004332.
21. Bataller A, Loghavi S, Gerstein Y, Bazinet A, Sasaki K, Chien KS, Hammond D, Montalban-Bravo G, Borthakur G, Short N, Issa GC, Kadia TM, Daver N, Tang G, Quesada A, Patel KP, Ravandi F, Fiskus W, Mill CP, Kantarjian HM, Bhalla K, Garcia-Manero G, Oran B, DiNardo CD. Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. Am J Hematol 98(11):1780-1790, 2023. e-Pub 2023. PMID: 37665752.
22. Setayesh SM, Ndacayisaba LJ, Rappard KE, Hennes V, Rueda LYM, Tang G, Lin P, Orlowski RZ, Symer DE, Manasanch EE, Shishido SN, Kuhn P. Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma. NPJ Precis Oncol 7(1):95, 2023. e-Pub 2023. PMID: 37723227.
23. Richard-Carpentier G, Rausch CR, Sasaki K, Hammond D, Morita K, Takahashi K, Tang G, Kanagal-Shamanna R, Bhalla K, Dinardo CD, Borthakur G, Pemmaraju N, Shpall EJ, Alousi A, Daver NG, Garcia-Manero G, Konopleva MY, Ravandi F, Kantarjian HM, Kadia TM. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2). Haematologica 108(9):2331-2342, 2023. e-Pub 2023. PMID: 36951163.
24. Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia 37(9):1919-1921, 2023. e-Pub 2023. PMID: 37443196.
25. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica 108(6):1604-1615, 2023. e-Pub 2023. PMID: 36453104.
26. Wang M, Ding Q, Gu J, Sfamenos SM, Huo L, Tang Z, Sun H, Robinson M, Tang G, Lim B, Wu Y, Albarracin CT, Sahin AA, Chen H. Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?. Clin Breast Cancer 23(4):415-422, 2023. e-Pub 2023. PMID: 36878823.
27. Desikan SP, Senapati J, Jabbour E, Abuasab T, Short N, Tang G, Wang S, Kebriaei P, Kadia T, Borthakur G, Ravandi F, Roberts K, Mullighan C, Konopleva M, Kantarjian H, Jain N. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. Am J Hematol 98(6):E142-E144, 2023. e-Pub 2023. PMID: 36877196.
28. Pasvolsky O, Milton DR, Rauf M, Ghanem S, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Rezvani K, Champlin R, Shpall EJ, Lin P, Qazilbash MH. Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients. Blood Cancer J 13(1):68, 2023. e-Pub 2023. PMID: 37137874.
29. Senapati J, Jabbour E, Konopleva M, Short NJ, Tang G, Daver N, Kebriaei P, Kadia T, Pemmaraju N, Takahashi K, DiNardo C, Sasaki K, Borthakur G, Thakral B, Kanagal-Shamanna R, Patel K, Ravandi F, Roberts K, Mullighan C, Kantarjian H, Jain N. Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO Precis Oncol 7:e2200707, 2023. e-Pub 2023. PMID: 37196217.
30. Pasvolsky O, Gaballa MR, Milton DR, Masood A, Sami SS, Tanner MR, Bashir Q, Srour S, Saini N, Ramdial J, Nieto Y, Tang G, Lin P, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience. Transplant Cell Ther 29(4):260.e1-260.e6, 2023. e-Pub 2023. PMID: 36646323.
31. Xu J, Li S, Yin CC, Patel KP, Tang G, Wang W, Miranda RN, Garces S, Tang Z, Lin P, Medeiros LJ. Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases. Hum Pathol 134:114-123, 2023. e-Pub 2023. PMID: 36584716.
32. Siddiqui M, Konoplev S, Issa G, Kantarjian H, Daver N, Ravandi F, Kadia T, Tang G, Wang SA, Thakral B, Medeiros LJ, Pozdnyakova O, Pierce S, Montalban-Bravo G, Chien K, Hammond D, Sasaki K, Garcia-Manero G, Hasserjian RP. Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. Am J Hematol 98(4):E91-E94, 2023. e-Pub 2023. PMID: 36661399.
33. Tang G, Li S, Toruner GA, Jain P, Tang Z, Hu S, Xu J, Cheng J, Robinson M, Vega F, Medeiros LJ. Clinical impact of 5'MYC or 3'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas. Cancer Genet 272-273:1-8, 2023. e-Pub 2023. PMID: 36566629.
34. Issa GC, Bidikian A, Venugopal S, Konopleva M, DiNardo CD, Kadia TM, Borthakur G, Jabbour E, Pemmaraju N, Yilmaz M, Short NJ, Maiti A, Sasaki K, Masarova L, Pierce S, Takahashi K, Tang G, Loghavi S, Patel K, Andreeff M, Bhalla K, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N. Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML. Blood Adv 7(6):933-942, 2023. e-Pub 2023. PMID: 36322818.
35. Qiu L, Xu J, Lin P, Cohen EN, Tang G, Wang SA, Khanlari M, Wang W, Khoury JD, Konoplev S, Yin CC, Jorgensen JL, Vega F, Medeiros LJ, Li S. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma. Haematologica 108(3):895-899, 2023. e-Pub 2023. PMID: 36325892.
36. Li S, Qiu L, Xu J, Lin P, Ok CY, Tang G, McDonnell TJ, James You M, Khanlari M, Miranda RN, Medeiros LJ. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37(2):422-432, 2023. e-Pub 2023. PMID: 36513804.
37. Qiu L, Wang SA, Tang G, Wang W, Lin P, Xu J, Yin CC, Khanlari M, Medeiros LJ, Li S. Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765805.
38. Tang Z, Wang W, Yang S, El Achi H, Fang H, Nahmod KA, Toruner GA, Xu J, Thakral B, Ayoub E, Issa GC, Yin CC, You MJ, Miranda RN, Khoury JD, Medeiros LJ, Tang G. 3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features. Cancers (Basel) 15(2), 2023. e-Pub 2023. PMID: 36672407.
39. Fang H, Khoury JD, Torres-Cabala CA, Ng SB, Xu J, El Hussein S, Hu S, Vega F, Li S, Tang Z, Tang G, Medeiros LJ, Wang W. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology 54(7):893-899, 2022. e-Pub 2022. PMID: 35864006.
40. Lachowiez CA, Reville PK, Kantarjian H, Jabbour E, Borthakur G, Daver N, Issa G, Furudate K, Tanaka T, Pierce S, Tang G, Patel KP, Medeiros J, Abbas HA, Haddad F, Hammond D, Short NJ, Maiti A, Yilmaz M, Sasaki K, Takahashi K, Pemmaraju N, Konopleva M, Garcia-Manero G, Ravandi F, Kadia TM, Loghavi S, DiNardo CD. Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. Am J Hematol 97(11):1443-1452, 2022. e-Pub 2022. PMID: 36054614.
41. Pasvolsky O, Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Tang G, Saini N, Ramdial J, Masood A, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma. Transplant Cell Ther 28(11):752.e1-752.e6, 2022. e-Pub 2022. PMID: 35940528.
42. Ndacayisaba LJ, Rappard KE, Shishido SN, Setayesh SM, Tang G, Lin P, Matsumoto N, Hsu CJ, Nevarez R, Velasco CR, Naghdloo A, Yang E, Kelly K, Hicks J, Mason J, Orlowski RZ, Manasanch EE, Kuhn P. Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms. Int J Mol Sci 23(21), 2022. e-Pub 2022. PMID: 36362214.
43. Saini NY, Swoboda DM, Greenbaum U, Ma J, Patel RD, Devashish K, Das K, Tanner MR, Strati P, Nair R, Fayad L, Ahmed S, Lee HJ, Iyer SP, Steiner R, Jain N, Nastoupil L, Loghavi S, Tang G, Bassett RL, Jain P, Wang M, Westin JR, Green MR, Sallman DA, Padron E, Davila ML, Locke FL, Champlin RE, Garcia-Manero G, Shpall EJ, Kebriaei P, Flowers CR, Jain MD, Wang F, Futreal AP, Gillis N, Neelapu SS, Takahashi K. Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. Blood Cancer Discov 3(5):385-393, 2022. e-Pub 2022. PMID: 35533245.
44. Wang X, Tang G, Hu Z, Fang H, Wang W, Tang Z, Toruner GA, Zhou T, DiNardo CD, Garcia-Manero G, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Hu S. Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival. Br J Haematol 198(3):604-608, 2022. e-Pub 2022. PMID: 35645146.
45. Cherng HJ, Khwaja R, Kanagal-Shamanna R, Tang G, Burger J, Thompson P, Ferrajoli A, Estrov Z, Sasaki K, Sampath D, Wang X, Kantarjian H, Keating M, Wierda WG, Jain N. TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis. Am J Hematol 97(8):1005-1012, 2022. e-Pub 2022. PMID: 35567779.
46. Gaballa MR, Ma J, Rauf M, Bassett R, Pasvolsky O, Tanner MR, Bashir Q, Srour SA, Saini N, Ramdial J, Nieto Y, Murphy R, Rezvani K, Tang G, Lin P, Lee HC, Patel KK, Ullah MR, Kaufman GP, Manasanch EE, Kebriaei P, Thomas SK, Weber DM, Shpall EJ, Champlin RE, Orlowski RZ, Qazilbash MH. KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma. Bone Marrow Transplant 57(7):1142-1149, 2022. e-Pub 2022. PMID: 35523847.
47. Kim K, Konopleva M, DiNardo CD, Borthakur G, Loghavi S, Tang G, Daver N, Pemmaraju N, Jabbour E, Rausch CR, Yilmaz M, Sasaki K, Short NJ, Jain N, Brandt M, Pierce S, Garcia-Manero G, Ravandi F, Kantarjian H, Kadia TM. Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. Am J Hematol 97(7):885-894, 2022. e-Pub 2022. PMID: 35413152.
48. Yin W, Guo M, Tang Z, Toruner GA, Cheng J, Medeiros LJ, Tang G. MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome. Cancers (Basel) 14(10), 2022. e-Pub 2022. PMID: 35626038.
49. Khanlari M, Yin CC, Takahashi K, Lachowiez C, Tang G, Loghavi S, Bah I, Wang W, Konoplev S, Medeiros LJ, Pemmaraju N, Khoury JD, Wang SA. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia 36(5):1343-1350, 2022. e-Pub 2022. PMID: 35279700.
50. Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Toruner GA, Hu S, Yin CC, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang Z. Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies. Cancer Genet 262-263:23-29, 2022. e-Pub 2022. PMID: 34974290.
51. Ndacayisaba LJ, Rappard KE, Shishido SN, Ruiz Velasco C, Matsumoto N, Navarez R, Tang G, Lin P, Setayesh SM, Naghdloo A, Hsu CJ, Maney C, Symer D, Bethel K, Kelly K, Merchant A, Orlowski R, Hicks J, Mason J, Manasanch EE, Kuhn P. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones. Curr Oncol 29(5):2954-2972, 2022. e-Pub 2022. PMID: 35621632.
52. Cai T, Gouble A, Black KL, Skwarska A, Naqvi AS, Taylor D, Zhao M, Yuan Q, Sugita M, Zhang Q, Galetto R, Filipe S, Cavazos A, Han L, Kuruvilla V, Ma H, Weng C, Liu CG, Liu X, Konoplev S, Gu J, Tang G, Su X, Al-Atrash G, Ciurea S, Neelapu SS, Lane AA, Kantarjian H, Guzman ML, Pemmaraju N, Smith J, Thomas-Tikhonenko A, Konopleva M. Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nat Commun 13(1):2228, 2022. e-Pub 2022. PMID: 35484100.
53. Tang G, Zou Y, Wang SA, Borthakur G, Toruner G, Hu S, Li S, Xu J, Medeiros LJ, Tang Z. 3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant. Ann Hematol 101(4):847-854, 2022. e-Pub 2022. PMID: 35184217.
54. Khanlari M, Li S, Miranda RN, Iyer S, Konoplev S, Lin P, Yin CC, Tang G, Qiu L, Vega F, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Mod Pathol 35(3):412-418, 2022. e-Pub 2022. PMID: 34628481.
55. Konoplev S, Wang X, Tang G, Li S, Wang W, Xu J, Pierce SA, Jia F, Jorgensen JL, Ravandi F, Issa GC, Medeiros LJ, Wang SA. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single-institution experience. Cytometry B Clin Cytom 102(2):123-133, 2022. e-Pub 2022. PMID: 34964255.
56. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. Mod Pathol 35(3):419-426, 2022. e-Pub 2022. PMID: 34608246.
57. Wang ML, Jain P, Zhao S, Lee HJ, Nastoupil L, Fayad L, Ok CY, Kanagal-Shamanna R, Hill HA, Yao Y, Hagemeister FB, Westin JR, Fowler N, Samaniego F, Steiner R, Nair R, Iyer SP, Navsaria L, Badillo M, Research Group MC, Feng L, Xuelin H, Nogueras Gonzalez GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Lin P, Wang SA, Jorgensen J, Yin CC, Li S, Patel KP, Vega F, Medeiros LJ, Flowers CR, Wang L. Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (=65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Lancet Oncol 23(3):406-415, 2022. e-Pub 2022. PMID: 35074072.
58. Gaballa MR, Ma J, Tanner MR, Al-Juhaishi T, Bashir Q, Srour SA, Saini NY, Ramdial JL, Nieto Y, Murphy R, Rezvani K, Tang G, Lee HC, Patel KK, Kaufman GP, Manasanch EE, Ullah MR, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leuk Lymphoma 63(3):710-721, 2022. e-Pub 2022. PMID: 34686083.
59. Liu H, Xu-Monette ZY, Tang G, Wang W, Kim Y, Yuan J, Li Y, Chen W, Li Y, Fedoriw GY, Zhu F, Fang X, Luedke C, Medeiros LJ, Young KH, Hu S. EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study. Histopathology 80(3):575-588, 2022. e-Pub 2022. PMID: 34637146.
60. Qiu L, Xu J, Tang G, Wang SA, Lin P, Ok CY, Garces S, Yin CC, Khanlari M, Vega F, Medeiros LJ, Li S. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall. Hum Pathol 119:59-68, 2022. e-Pub 2022. PMID: 34767860.
61. Jain P, Zhao S, Lee HJ, Hill HA, Ok CY, Kanagal-Shamanna R, Hagemeister FB, Fowler N, Fayad L, Yao Y, Liu Y, Moghrabi OB, Navsaria L, Feng L, Nogueras Gonzalez GM, Xu G, Thirumurthi S, Santos D, Iliescu C, Tang G, Medeiros LJ, Vega F, Avellaneda M, Badillo M, Flowers CR, Wang L, Wang ML. Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. J Clin Oncol 40(2):202-212, 2022. e-Pub 2022. PMID: 34797699.
62. Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, Miranda RN, Iyer S, You MJ, Xu J. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers (Basel) 13(24), 2021. e-Pub 2021. PMID: 34944936.
63. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury JD, Issa GC, Haddad F, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Konopleva MY, Daver NG, Kadia T, Garcia-Manero G, Garris R, O'Brien S, Jabbour E. Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience. Blood Adv 5(23):5415-5419, 2021. e-Pub 2021. PMID: 34525185.
64. Toruner GA, Thakral B, Tang Z, Tang G, Medeiros LJ, Oran B. Clonal cytogenetic abnormalities in donor-derived cells after sex mismatched allogeneic stem cell transplantation. Cancer Genet 258-259:120-130, 2021. e-Pub 2021. PMID: 34715428.
65. Qiu L, Tang G, Li S, Wang W, Wang SA, Xu J. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor lymphoblastic leukemia. EJHaem 2(4):895-896, 2021. e-Pub 2021. PMID: 35845203.
66. Huang X, Chen H, Ding Q, Robinson MK, Moseley TW, Bassett RL, Tang G, Lim B, Sahin AA. Clinicopathological features of and neoadjuvant therapy for HER2-positive classic invasive lobular carcinoma. Hum Pathol 117:51-59, 2021. e-Pub 2021. PMID: 34363799.
67. Kim K, Maiti A, Loghavi S, Pourebrahim R, Kadia TM, Rausch CR, Furudate K, Daver NG, Alvarado Y, Ohanian M, Sasaki K, Short NJ, Takahashi K, Yilmaz M, Tang G, Ravandi F, Kantarjian HM, DiNardo CD, Konopleva MY. Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax. Cancer 127(20):3772-3781, 2021. e-Pub 2021. PMID: 34255353.
68. Yang RK, Toruner GA, Wang W, Fang H, Issa GC, Wang L, Quesada AE, Thakral B, Patel KP, Peng G, Liu S, Yin CC, Borthakur G, Tang Z, Wang SA, Miranda RN, Khoury JD, Medeiros LJ, Tang G. CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771519.
69. Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, DiNardo CD, Borthakur G, Pierce SA, Jabbour E, Wang SA, Bueso-Ramos C, Loghavi S, Tang G, Cheung CM, Alexander L, Kornblau S, Andreeff M, Garcia-Manero G, Ravandi F, Konopleva MY, Daver N. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer 127(20):3761-3771, 2021. e-Pub 2021. PMID: 34171128.
70. Tang Z, Kanagal-Shamanna R, Tang G, Patel K, Medeiros LJ, Toruner GA. Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia. Leuk Res 108:106616, 2021. e-Pub 2021. PMID: 34022744.
71. Tang G, Tam W, Short NJ, Bose P, Wu D, Hurwitz SN, Bagg A, Rogers HJ, Hsi ED, Quesada AE, Wang W, Miranda RN, Bueso-Ramos CE, Medeiros LJ, Nardi V, Hasserjian RP, Arber DA, Orazi A, Foucar K, Wang SA. Myeloid/lymphoid neoplasms with FLT3 rearrangement. Mod Pathol 34(9):1673-1685, 2021. e-Pub 2021. PMID: 33990705.
72. Khanlari M, Wang SA, Tang G, Saluja K, Medeiros LJ, Thakral B. CD45-negative follicular lymphoma: A rare diagnostic pitfall of a common entity. Cytometry B Clin Cytom 100(4):406-408, 2021. e-Pub 2021. PMID: 32851738.
73. Yin W, Cheng J, Tang Z, Toruner G, Hu S, Guo M, Robinson M, Medeiros LJ, Tang G. MET Amplification (MET/CEP7 Ratio = 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer. Clin Lung Cancer 22(4):e512-e518, 2021. e-Pub 2021. PMID: 33288441.
74. Fang H, Yabe M, Zhang X, Kim Y, Wu X, Wei P, Chi S, Zheng L, Garcia-Manero G, Shao L, Yuan J, Shen Y, Zheng G, Tang G, Wang W, Loghavi S, Shen Q, Yuan Y, He R, Chen D, Medeiros LJ, Hu S. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases. Mod Pathol 34(6):1143-1152, 2021. e-Pub 2021. PMID: 33558656.
75. Jain P, Kanagal-Shamanna R, Zhang S, Ok CY, Navsaria L, Nastoupil L, Lee HJ, Tang G, Yin CC, Badillo M, Nair R, Li S, Patel KM, Flowers C, Vega F, Wang L, Wang ML. Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. Am J Hematol 96(5):E137-E140, 2021. e-Pub 2021. PMID: 33491779.
76. Wang L, Tang G, Medeiros LJ, Xu J, Huang W, Yin CC, Wang M, Jain P, Lin P, Li S. MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica 106(5):1381-1389, 2021. e-Pub 2021. PMID: 32273477.
77. Sun H, Chen H, Crespo J, Tang G, Robinson M, Lim B, Sahin AA. Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy. Eur J Breast Health 17(2):128-136, 2021. e-Pub 2021. PMID: 33870112.
78. Alotaibi AS, Yilmaz M, Kanagal-Shamanna R, Loghavi S, Kadia TM, DiNardo CD, Borthakur G, Konopleva M, Pierce SA, Wang SA, Tang G, Guerra V, Samra B, Pemmaraju N, Jabbour E, Short NJ, Issa GC, Ohanian M, Garcia-Manero G, Bhalla KN, Patel KP, Takahashi K, Andreeff M, Cortes JE, Kantarjian HM, Ravandi F, Daver N. Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors. Blood Cancer Discov 2(2):125-134, 2021. e-Pub 2021. PMID: 33681815.
79. Hao S, Lu X, Gong Z, Bassett RL, Hu S, Konoplev SN, Tang G, Li S, Xu J, Khanlari M, Lee HC, Manasanch EE, Weber DM, Orlowski RZ, Jeffrey Medeiros L, Lin P. The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma. Mod Pathol 34(2):327-335, 2021. e-Pub 2021. PMID: 32908255.
80. Lyapichev KA, Tang G, Li S, You MJ, Cheng TJ, Miranda RN, Iyer S, Yin CC, Konoplev S, Bueso-Ramos C, Vega F, Medeiros LJ, Xu J. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol 108:22-31, 2021. e-Pub 2021. PMID: 33221344.
81. Yin W, Liu W, Guo M, Tang Z, Toruner G, Robinson M, Cheng J, Hu S, Medeiros LJ, Tang G. Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome. Exp Mol Pathol 118:104572, 2021. e-Pub 2021. PMID: 33189723.
82. Ronaghy A, Hu S, Tang Z, Wang W, Tang G, Loghavi S, Li S, Thakral B, Medeiros LJ, Muzzafar T. Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities. Mod Pathol 34(2):300-313, 2021. e-Pub 2021. PMID: 33110238.
83. Mendt M, Daher M, Basar R, Shanley M, Kumar B, Wei Inng FL, Acharya S, Shaim H, Fowlkes N, Tran JP, Gokdemir E, Uprety N, Nunez-Cortes AK, Ensley E, Mai T, Kerbauy LN, Melo-Garcia L, Lin P, Shen Y, Mohanty V, Lu J, Li S, Nandivada V, Wang J, Banerjee P, Reyes-Silva F, Liu E, Ang S, Gilbert A, Li Y, Wan X, Gu J, Zhao M, Baran N, Muniz-Feliciano L, Wilson J, Kaur I, Gagea M, Konopleva M, Marin D, Tang G, Chen K, Champlin R, Rezvani K, Shpall EJ. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. Front Immunol 12:631353, 2021. e-Pub 2021. PMID: 34017325.
84. Alotaibi AS, Abdulrazzaq M, Patel KP, Ravandi F, Konoplev S, Bueso-Ramos C, Yin CC, Muzzafar T, Tang G, Futreal A, Jain N, Konopleva MY, Pemmaraju N. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma 61(12):3018-3020, 2020. e-Pub 2020. PMID: 32657180.
85. Chen Z, Hu S, Wang SA, Konopleva M, Tang Z, Xu J, Li S, Toruner G, Thakral B, Medeiros LJ, Tang G. Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia. Leuk Lymphoma 61(12):2831-2838, 2020. e-Pub 2020. PMID: 32700989.
86. Gupta SK, Jain N, Tang G, Futreal A, Wang SA, Khoury JD, Yang RK, Fang H, Patel KP, Luthra R, Routbort M, Barkoh BA, Chen W, Mao X, Zhang J, Medeiros LJ, Bueso-Ramos CE, Loghavi S. A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications. J Natl Compr Canc Netw 18(10):1300-1304, 2020. e-Pub 2020. PMID: 33022638.
87. Tang Z, Toruner GA, Tang G, Cameron Yin C, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol 33(10):2035-2045, 2020. e-Pub 2020. PMID: 32404952.
88. Tang Z, Toruner GA, Tang G, Yin CC, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Correction: Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol 33(10):2088, 2020. e-Pub 2020. PMID: 32737448.
89. Tang G, Qiao Y, Yu L, Li CM, Lu Z. Re-stickable All-Solid-State Supercapacitor Supported by Cohesive Thermoplastic for Textile Electronics. ACS Appl Mater Interfaces 12(40):45322-45331, 2020. e-Pub 2020. PMID: 32914958.
90. Saini N, Bashir Q, Milton DR, Tang G, Delgado R, Rondon G, Popat UR, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Mehta R, Srour S, Khouri IF, Weber DM, Thomas SK, Lee HC, Patel KK, Orlowski RZ, Champlin RE, Qazilbash MH. Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM. Blood Adv 4(19):4834-4837, 2020. e-Pub 2020. PMID: 33027527.
91. Liu W, Burger JA, Xu J, Tang Z, Toruner G, Khanlari M, Medeiros LJ, Tang G. LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia. Ann Hematol 99(10):2343-2349, 2020. e-Pub 2020. PMID: 32833105.
92. Xie W, Xu J, Hu S, Li S, Wang W, Cameron Yin C, Toruner G, Tang Z, Jeffrey Medeiros L, Tang G. iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome. Mod Pathol 33(7):1389-1397, 2020. e-Pub 2020. PMID: 32034282.
93. Tang Z, Chen H, Hong L, Tang G, Toruner GA, Wang W, Roy Chowdhuri S, Yin W, Jung HS, Gu J, Routbort MJ, Zhang J, Khoury JD, Medeiros LJ. Inconsistent Intersample ALK FISH Results in Patients with Lung Cancer: Analysis of Potential Causes. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32674491.
94. Gong Z, Zhou T, Liu H, Tang G, Yin CC, Wang W, Medeiros LJ, Hu S. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia. Br J Haematol 189(5):e207-e211, 2020. e-Pub 2020. PMID: 32237084.
95. Fang H, Tang G, Loghavi S, Greipp P, Wang W, Verstovsek S, Medeiros LJ, Reichard KK, Miranda RN, Wang SA. Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms. Histopathology 76(7):1042-1054, 2020. e-Pub 2020. PMID: 32083752.
96. Zhao S, Kanagal-Shamanna R, Navsaria L, Ok CY, Zhang S, Nomie K, Han G, Hao D, Hill HA, Jiang C, Yao Y, Nastoupil L, Westin J, Fayad L, Nair R, Steiner R, Ahmed S, Samaniego F, Iyer SP, Oriabure O, Chen W, Song X, Zhang J, Badillo M, Moghrabi O, Aranda J, Tang G, Yin CC, Patel K, Medeiros LJ, Li S, Vega F, Thirumurthi S, Xu G, Neelapu S, Flowers CR, Romaguera J, Fowler N, Wang L, Wang ML, Jain P. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol 95(6):623-629, 2020. e-Pub 2020. PMID: 32239765.
97. Varma A, Sui D, Milton DR, Tang G, Saini N, Hasan O, Mukherjee A, Joseph JJ, Bashir Q, Rondon G, Srour S, Popat UR, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Mehta R, Khouri IF, Ahmed H, Iyer S, Weber DM, Thomas SK, Manasanch E, Lee HC, Patel K, Ciurea SO, Shpall EJ, Orlowski RZ, Champlin RE, Qazilbash MH. Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis. Biol Blood Marrow Transplant 26(4):665-671, 2020. e-Pub 2020. PMID: 31881283.
98. Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma. Eur J Haematol 104(4):336-343, 2020. e-Pub 2020. PMID: 31944390.
99. Shen J, Medeiros LJ, Li S, Wang SA, Lin P, Khanlari M, Iyer SP, Yin CC, Tang G, Jorgensen JL, Hu S, Miranda RN, Xu J. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma. Hum Pathol 98:1-9, 2020. e-Pub 2020. PMID: 32032618.
100. Liu H, Miao Y, Ferrajoli A, Tang G, McDonnell T, Medeiros LJ, Hu S. Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy. Am J Hematol. e-Pub 2020. PMID: 32162729.
101. Shen J, Li S, Medeiros LJ, Lin P, Wang SA, Tang G, Yin CC, You MJ, Khoury JD, Iyer SP, Miranda RN, Xu J. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Mod Pathol 33(3):324-333, 2020. e-Pub 2020. PMID: 31383967.
102. Xie W, Tang G, Li S, Yin CC, Xu J. Anaplastic multiple myeloma resembling dysplastic megakaryocytes. Clin Case Rep 8(3):568-569, 2020. e-Pub 2020. PMID: 32185061.
103. Jain P, Zhang S, Kanagal-Shamanna R, Ok CY, Nomie K, Gonzalez GN, Gonzalez-Pagan O, Hill HA, Lee HJ, Fayad L, Westin J, Nastoupil L, Hagemeister F, Chen W, Oriabure O, Badillo M, Jiang C, Yixin Y, Li S, Tang G, Yin CC, Patel KP, Medeiros LJ, Nair R, Ahmed S, Iyer SP, Thirumurthi S, Champlin R, Xu G, Tinsu P, Santos D, Wang R, Han G, Zhang J, Song X, Neelapu S, Romaguera J, Futreal A, Flowers C, Fowler N, Wang L, Wang ML. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv 4(6):1038-1050, 2020. e-Pub 2020. PMID: 32191807.
104. Toruner GA, Tang Z, Tang G, Medeiros LJ, Hu S. Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors. Cancer Genet 241:57-60, 2020. e-Pub 2020. PMID: 31870845.
105. Chen Z, Ok CY, Wang W, Goswami M, Tang G, Routbort M, Jorgensen JL, Medeiros LJ, Wang SA. Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones). Cytometry B Clin Cytom 98(1):36-42, 2020. e-Pub 2020. PMID: 31211490.
106. Saglam O, Tang Z, Tang G, Medeiros LJ, Toruner GA. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma. PLoS One 15(9):e0238477, 2020. e-Pub 2020. PMID: 32877461.
107. Xie W, Chen Z, Wang SA, Hu S, Li S, Miranda RN, Medeiros LJ, Tang G. Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Leuk Lymphoma 60(12):2993-3001, 2019. e-Pub 2019. PMID: 31017498.
108. Bah I, Li S, Yin CC, Tang G, Xu J. Merkel cell carcinoma mimicking transformed chronic lymphocytic leukemia/small lymphocytic lymphoma. Clin Case Rep 7(11):2256-2257, 2019. e-Pub 2019. PMID: 31788294.
109. Chen Z, Wang SA, Goswami M, Tang G, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts. Leuk Res 86:106227, 2019. e-Pub 2019. PMID: 31557598.
110. Saini N, Ma J, Milton DR, Patel R, Varma A, Bashir Q, Delgado R, Mukherjee A, Rondon G, Popat UR, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Tang G, Mehta R, Srour S, Khouri IF, Iyer S, Weber DM, Thomas SK, Lee HC, Manasanch EE, Patel KK, Orlowski RZ, Champlin RE, Qazilbash MH. Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis. Clin Cancer Res 25(22):6781-6787, 2019. e-Pub 2019. PMID: 31481508.
111. Hu B, Patel KP, Chen HC, Wang X, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating M, Wierda WG. Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients. Br J Haematol 187(3):307-318, 2019. e-Pub 2019. PMID: 31243771.
112. Gong Z, Xu ML, Chen M, Cui W, Kantarjian HM, Cortes JE, Zhou T, Tang G, Wang W, Medeiros LJ, Hu S. Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia. Am J Hematol 94(10):E256-E259, 2019. e-Pub 2019. PMID: 31273842.
113. Chen Z, Sun Y, Xie W, Wang SA, Hu S, Li S, Tang Z, Toruner G, Medeiros LJ, Tang G. Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?. Cancer Med 8(9):4093-4099, 2019. e-Pub 2019. PMID: 31173486.
114. Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M, Miranda RN, Medeiros LJ, Li S. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis. Hum Pathol 89:71-80, 2019. e-Pub 2019. PMID: 31054894.
115. Tang Z, Tang G, Hu S, Patel KP, Cameron Yin C, Wang W, Lin P, Toruner GA, Ok CY, Gu J, Lu X, Khoury JD, Jeffrey Medeiros L. Data on MECOM rearrangement-driven chromosomal aberrations in myeloid malignancies. Data Brief 24:104025, 2019. e-Pub 2019. PMID: 31193989.
116. Hu B, Patel KP, Chen HC, Wang X, Wang F, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Wierda WG. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. Br J Haematol 185(5):852-864, 2019. e-Pub 2019. PMID: 30924136.
117. Xie W, Hu S, Xu J, Chen Z, Medeiros LJ, Tang G. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults. Ann Hematol 98(5):1149-1157, 2019. e-Pub 2019. PMID: 30759270.
118. Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Am J Surg Pathol 43(5):710-716, 2019. e-Pub 2019. PMID: 30768440.
119. Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S, Lake JI, Margolskee EM, Rogers HJ, Miranda RN, Bueso-Ramos C C, Hsi ED, Orazi A, Hasserjian RP, Arber DA, Bagg A, Wang SA. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Mod Pathol 32(4):490-498, 2019. e-Pub 2019. PMID: 30401948.
120. Tang Z, Tang G, Hu S, Patel KP, Yin CC, Wang W, Lin P, Toruner GA, Ok CY, Gu J, Lu X, Khoury JD, Medeiros LJ. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations. Cancer Genet 233-234:21-31, 2019. e-Pub 2019. PMID: 31109591.
121. Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. J Mol Diagn 21(2):343-351, 2019. e-Pub 2019. PMID: 30576868.
122. Angelova EA, Li S, Wang W, Bueso-Ramos C, Tang G, Medeiros LJ, Lin P. IgM plasma cell myeloma in the era of novel therapy: a clinicopathological study of 17 cases. Hum Pathol 84:321-334, 2019. e-Pub 2019. PMID: 30266252.
123. Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 73:86-94, 2018. e-Pub 2018. PMID: 30248580.
124. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, Konoplev S, Yin CC, Xu J, Oki Y, Li S. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol, 2018. e-Pub 2018. PMID: 29785017.
125. Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol, 2018. e-Pub 2018. PMID: 30181564.
126. Garces S, Khoury JD, Kanagal-Shamanna R, Salem A, Wang SA, Ok CY, Hu S, Patel KP, Routbort MJ, Luthra R, Tang G, Schlette EJ, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype and TP53 disruption. Hum Pathol, 2018. e-Pub 2018. PMID: 30086334.
127. Ok CY, Loghavi S, Sui D, Wei P, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Tang G, Tang Z, Jorgensen JL, Luthra R, Ravandi F, Kantarjian HM, DiNardo CD, Medeiros LJ, Wang SA, Patel KP. Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia. Haematologica, 2018. e-Pub 2018. PMID: 30171025.
128. Liu H, Wang SA, Schlette EJ, Xu J, Jorgensen JL, Cameron Yin C, Li S, Jeffrey Medeiros L, Tang G. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Ann Hematol, 2018. e-Pub 2018. PMID: 29872884.
129. Boddu PC, Wang SA, Pemmaraju N, Tang Z, Hu S, Li S, Xu J, Medeiros LJ, Tang G. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms. Leuk Res 66:73-78, 2018. e-Pub 2018. PMID: 29407586.
130. Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol 97(3):425-434, 2018. e-Pub 2018. PMID: 29285580.
131. Kurt H, Zheng L, Kantarjian HM, Tang G, Ravandi-Kashani F, Garcia-Manero G, Gong Z, Amin HM, Konoplev SN, Routbort MJ, Han X, Wang W, Medeiros LJ, Hu S. Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome. Mod Pathol. e-Pub 2018. PMID: 29449681.
132. Xu J, Medeiros LJ, Saksena A, Zhou J, Li J, Yin CC, Tang G, Lin P, Li S. CD10-Positive Mantle Cell Lymphoma: Clinicopathologic and Prognostic Study of 30 Cases. Oncotarget 9(14):11441-11450, 2018. e-Pub 2018. PMID: 29545910.
133. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 Expression in Mantle Cell Lymphoma Identifies a Unique Subgroup of Patients with Frequent IGHV Mutations, Absence of SOX11 Expression, and an Indolent Clinical Course. Mod Pathol 31(2):327-336, 2018. e-Pub 2018. PMID: 28984300.
134. Tang Z, Zhang J, Lu X, Wang W, Chen H, Robinson MK, Cheng J, Tang G, Medeiros LJ. Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma. Mod Pathol 31(2):307-312, 2018. e-Pub 2018. PMID: 28914263.
135. Li J, Xu J, Abruzzo LV, Lu G, Tang G, Li S, You J, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LF, Yin CC. Acute myeloid leukemia with t(4;12)(q12;p13): An aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(13):10987-10994, 2017. e-Pub 2017. PMID: 29541391.
136. Strati P, Tang G, Duose DY, Mallampati S, Luthra R, Patel KP, Hussaini M, Mirza AS, Komrokji RS, Oh S, Mascarenhas J, Najfeld V, Subbiah V, Kantarjian H, Garcia-Manero G, Verstovsek S, Daver N. Myeloid/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma:1-5. e-Pub 2017. PMID: 29119847.
137. Issa GC, Kantarjian HM, Gonzalez GN, Borthakur G, Tang G, Wierda WG, Sasali K, Short NJ, Ravandi-Kashani F, Kadia TM, Patel KP, Luthra R, Ferrajoli A, Garcia-Manero G, Rios M, Dellasala SE, Jabbour E, Cortes JE. Clonal chromosomal abnormalities appearing in Philadelphia negative metaphases during CML treatment. Blood. e-Pub 2017. PMID: 28835440.
138. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B cell lymphoma. Mod Pathol, 2017. e-Pub 2017. PMID: 28776574.
139. Jain N, Lu X, Daver N, Thakral B, Wang SA, Konoplev S, Patel K, Kanagal-Shamanna R, Valentine M, Tang G, Pemmaraju N, Jorgensen J, Kebriaei P, Nunez CA, Wierda W, Jabbour E, Roberts KG, Mullighan CG, Kantarjian H, Konopleva M. Concurrent diagnosis of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. Haematologica. e-Pub 2017. PMID: 28860345.
140. Showalter JA, Tandon N, Zhao B, Tang G, Nguyen ND, Medeiros LJ. Myeloid sarcoma in a patient with myelodysplastic syndrome associated with del(5q): case report and literature review. Ann Clin Lab Sci. e-Pub 2017. PMID: 28801374.
141. Kanagal-Shamanna R, Jain P, Takahashi K, Short NJ, Tang G, Issa GC, Ravandi F, Garcia-Manero G, Yin CC, Luthra R, Patel KP, Khoury JD, Montalban-Bravo G, Sasaki K, Kadia TM, Borthakur G, Konopleva M, Jain N, Garris R, Pierce S, Wierda W, Estrov Z, Cortes J, O’Brien S, Kantarjian H, Jabbour E. TP53 mutation does not confer a poor outcome in adult all treated with frontline hyper-CVAD-based regimens. Cancer, 2017. e-Pub 2017. PMID: 28608976.
142. Tang Z, Xu J, Wang SA, Li S, Young KH, Medeiros LJ, Tang G. Acquisition of t(2;18)(p11.2;q21.3) and NOTCH1 mutations May Accelerate Richter’s Transformation in Chronic Lymphocytic Leukemia with t(14;19)(q32;q13) and Trisomy 12. Translational Genetics and Genomics. e-Pub 2017.
143. Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X. Myeloproliferative Neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: A Meta-Analysis of 20 Cases Shows Cytogenetic Progression with B-Lymphoid Blast Phase. Human Pathology, 2017. e-Pub 2017. PMID: 28551329.
144. Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. Am J Hematol 92(5):441-447, 2017. e-Pub 2017. PMID: 28194886.
145. Ballester LY, Huse JT, Tang G, Fuller GN. Molecular Classification of Adult Diffuse Gliomas: Conflicting IDH1/IDH2, ATRX and 1p/19q Results. Human Pathology, 2017. e-Pub 2017. PMID: 28549927.
146. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Bassett R, Ma J, Pierce S, Zuo W, Carballo-Zarate AJ, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica. e-Pub 2017. PMID: 28473622.
147. Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study. Am J Clin Pathol 147(4):411-419, 2017. e-Pub 2017. PMID: 28375434.
148. Gur HD, Wang SA, Tang Z, Hu S, Li S, Medeiros LJ, Tang G. Clinical significance of isolated del(7p) in myeloid neoplasms. Leuk Res 55:18-22, 2017. e-Pub 2017. PMID: 28119224.
149. Thakral B, Medeiros LJ, Desai P, Lin P, Yin CC, Tang G, Khoury JD, Hu S, Xu J, Loghavi S, Hu B, Oki Y, Li S. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol 98(4):415-421, 2017. e-Pub 2017. PMID: 28039906.
150. Hu Z, Medeiros LJ, Wang W, Chen Z, Tang G, Hodjat P, Yang S, Fang L, Li Y, Verstovsek S, Hu S. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms. Mod Pathol. e-Pub 2017. PMID: 28338652.
151. Zuo W, Wang SA, DiNardo C, Yabe M, Li S, Medeiros LJ, Tang G. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not MLL gene. J Clin Pathol 70(3):244-249, 2017. e-Pub 2017. PMID: 27496968.
152. Gong Z, Zheng L, Tang Z, Chen Z, Wang W, Bai S, Tang G, Jeffrey Medeiros L, Hu S. Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Ann Hematol 96(3):501-504, 2017. e-Pub 2017. PMID: 27915425.
153. Salem A, Loghavi S, Tang G, Huh YO, Jabbour EJ, Kantarjian H, Wang W, Hu S, Luthra R, Medeiros LJ, Khoury JD. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm. Am J Hematol. e-Pub 2017. PMID: 28253536.
154. Huang L, Wang SA, DiNardo C, Li S, Hu S, Xu J, Zhou W, Goswami M, Medeiros LJ, Tang G. Tetraploidy/near-tetraploidy acute myeloid leukemia. Leuk Res 53:20-27, 2017. e-Pub 2017. PMID: 27951415.
155. Wang XJ, Medeiros L, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, Li S. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Mod Pathol 30(2):194-203, 2017. e-Pub 2017. PMID: 27739436.
156. Xu J, Oki Y, Saksena A, Desai P, Lin P, Tang G, Yin CC, You MJ, Thakral B, Medeiros LJ, Li S. CD30 expression and prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma. Hum Pathol 60:160-166, 2017. e-Pub 2017. PMID: 27816715.
157. Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, Bhagat G, Chen W, Li S, Young KH, Miranda RN. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol 41(1):82-93, 2017. e-Pub 2017. PMID: 27755009.
158. Sun Y, Tang G, Hu Z, Thakral B, Medeiros LJ, Wang SA. Comparison of Karyotyping, TCL1 Fluorescence in situ Hybridization and TCL1 Immunohistochemistry in T-cell Prolymphocytic Leukemia. J Clin Pathol, 2017. e-Pub 2017. PMID: 28821581.
159. Boddu P, Yin CC, Kanagala R, Tang G, Thakral B, Kadia T, Konopleva M, Jabbour E, Jain N. An unsuspected finding of t(9;22): a rare case of Philadelphia chromosome-positive B-lymphoblastic lymphoma. Case Reports in Hematology, 2017. e-Pub 2017. PMID: 29075538.
160. Boddu P, Schlette E, Thakral B, Tang G, Pemmaraju N, Kadia P, Ferrajoli A, Ravandi F, Wierda W, Jain N. Acute Promyelocytic Leukemia in a Patient with Chronic Lymphocytic Leukemia – A Case Report. Hematology/Oncology and Stem cell Therapy, 2017. e-Pub 2017. PMID: 28830803.
161. Tang G, Bueso-Ramos CE, Li S, Medeiros LJ, Wang SA. Acquired 11q23/MLL rearrangement of unknown clinical significance. Int J Clin Exp Pathol 10(8):9048-9051, 2017. e-Pub 2017.
162. Gong Z, Medeiros LJ, Cortes JE, Zheng L, Khoury JD, Wang W, Tang G, Loghavi S, Luthra R, Yang W, Kantarjian HM, Hu S. Clinical and Prognostic Significance of e1a2 BCR-ABL1 Transcript Subtype in Patients with Chronic Myeloid Leukemia. Blood Cancer Journal 7(7), 2017. e-Pub 2017. PMID: 28708130.
163. Tang Z, Li Y, Wang SA, Hu S, Li S, Lu X, Khoury JD, Medeiros LJ, Tang G. Clinical significance of acquired loss of the X chromosome in bone marrow. Leuk Res 47:109-13, 2016. e-Pub 2016. PMID: 27299973.
164. Huh YO, Tang G, Talwalkar SS, Khoury JD, Ohanian M, Bueso-Ramos CE, Abruzzo LV. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype. Cancer Genet 209(7-8):313-20, 2016. e-Pub 2016. PMID: 27318442.
165. Goswami RS, Wang SA, DiNardo C, Tang Z, Li Y, Zuo W, Hu S, Li S, Medeiros LJ, Tang G. Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms. Mod Pathol 29(7):727-34, 2016. e-Pub 2016. PMID: 27056073.
166. Wang W, Cortes JE, Tang G, Khoury JD, Wang S, Bueso-Ramos CE, DiGiuseppe JA, Chen Z, Kantarjian HM, Medeiros LJ, Hu S. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127(22):2742-50, 2016. e-Pub 2016. PMID: 27006386.
167. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Histopathology 68(7):1090-8, 2016. e-Pub 2016. PMID: 26426741.
168. Jain P, Tang G, Huh YO, Yin CC, Zuo Z, Pemmaraju N, Estrov Z, Daver N. Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. Am J Hematol 91(6):647-8, 2016. e-Pub 2016. PMID: 26799924.
169. Ouyang J, Goswami M, Peng J, Zuo Z, Daver N, Borthakur G, Tang G, Medeiros LJ, Jorgensen JL, Ravandi F, Wang SA. Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid Leukemia. Am J Clin Pathol 145(6):769-77, 2016. e-Pub 2016. PMID: 27298396.
170. Wang W, Tang G, Kadia T, Lu X, Li Y, Huang L, Montenegro-Garreaud X, Miranda RN, Wang SA. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement. J Natl Compr Canc Netw 14(6):708-11, 2016. e-Pub 2016. PMID: 27283163.
171. Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget 7(25):38122-38132, 2016. e-Pub 2016. PMID: 27203548.
172. Li Y, Hu S, Wang SA, Li S, Huh YO, Tang Z, Medeiros LJ, Tang G. The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Mod Pathol 29(5):444-51, 2016. e-Pub 2016. PMID: 26916070.
173. Yabe M, Medeiros LJ, Tang G, Wang SA, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, Routbort M, Luthra R, Fanale MA, Bueso-Ramos CE, Jorgensen JL, Vega F, Chen W, Hoehn D, Konoplev S, Milton DR, Wistuba I, Li S, You MJ, Young KH, Miranda RN. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol 40(5):676-88, 2016. e-Pub 2016. PMID: 26872013.
174. Yabe M, Medeiros LJ, Tang G, Wang SA, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Hum Pathol 50:109-17, 2016. e-Pub 2016. PMID: 26997444.
175. Li S, Weiss VL, Wang XJ, Desai PA, Hu S, Yin CC, Tang G, Reddy NM, Medeiros LJ, Lin P. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol 40(2):253-61, 2016. e-Pub 2016. PMID: 26448193.
176. Sevcikova K, Zhuang Z, Garcia-Manero G, Alvarez RH, Kantarjian HM, Mego M, Albarracin C, Tang G, Strom SS, Medeiros LJ, Hortobagyi GN, Reuben JM, Khoury JD. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment. Leukemia 30(1):242-7, 2016. e-Pub 2016. PMID: 25975189.
177. Peng J, Zuo Z, Fu B, Oki Y, Tang G, Goswami M, Priyanka P, Muzzafar T, Medeiros LJ, Luthra R, Wang SA. Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation. Eur J Haematol 96(1):65-71, 2016. e-Pub 2016. PMID: 25809997.
178. Tang Z, Medeiros LJ, Yin CC, Wang W, Lu X, Young KH, Khoury JD, Tang G. Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists. Mol Cytogenet 9:62, 2016. e-Pub 2016. PMID: 27508005.
179. Tang Z, Tang G, Wang SA, Lu X, Young KH, Bueso-Ramos CE, Alvarado Y, Medeiros LJ, Khoury JD. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review. Mol Cytogenet 9:23, 2016. e-Pub 2016. PMID: 26925167.
180. Peng J, Hasserjian RP, Tang G, Patel KP, Goswami M, Jabbour EJ, Garcia-Manero G, Medeiros LJ, Wang SA. Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response. Leuk Lymphoma 57(4):812-9, 2016. e-Pub 2016. PMID: 26293512.
181. Wang W, Cortes JE, Lin P, Khoury JD, Ai D, Tang Z, Tang G, Jorgensen JL, Medeiros LJ, Hu S. Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia 29(11):2263-6, 2015. e-Pub 2015. PMID: 25931274.
182. Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang SA. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. Am J Hematol 90(10):882-7, 2015. e-Pub 2015. PMID: 26148174.
183. Sanford D, DiNardo CD, Tang G, Cortes JE, Verstovsek S, Jabbour E, Ravandi F, Kantarjian H, Garcia-Manero G. Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival. Clin Lymphoma Myeloma Leuk 15(9):556-62, 2015. e-Pub 2015. PMID: 26141213.
184. Yin CC, Tang G, Lu G, Feng X, Keating MJ, Medeiros LJ, Abruzzo LV. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. Mod Pathol 28(8):1130-7, 2015. e-Pub 2015. PMID: 25953391.
185. Shen Q, Ouyang J, Tang G, Jabbour EJ, Garcia-Manero G, Routbort M, Konoplev S, Bueso-Ramos C, Medeiros LJ, Jorgensen JL, Wang SA. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response. Eur J Haematol 95(2):168-76, 2015. e-Pub 2015. PMID: 25354960.
186. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 28(8):1014-22, 2015. e-Pub 2015. PMID: 26044451.
187. Tang G, Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, DiNardo C, Medeiros LJ. Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant. Am J Clin Pathol 144(1):78-86, 2015. e-Pub 2015. PMID: 26071464.
188. Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng SB, Tang G, Hu S, Yin CC, Miranda RN, Medeiros LJ, Khoury JD. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol 8:65, 2015. e-Pub 2015. PMID: 26055271.
189. Yabe M, Tang G, Garcia-Manero G, Loghavi S, Lu X, Miranda RN, Medeiros LJ, Kantarjian HM, Bueso-Ramos CE, Khoury JD. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features. Clin Lymphoma Myeloma Leuk 15 Suppl:S85-90, 2015. e-Pub 2015. PMID: 26297286.
190. Ouyang J, Goswami M, Tang G, Peng J, Ravandi F, Daver N, Routbort M, Konoplev S, Lin P, Medeiros LJ, Jorgensen JL, Wang SA. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia. Am J Hematol 90(6):504-10, 2015. e-Pub 2015. PMID: 25732229.
191. Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Peng J, Tang G, Goswami M, Young KH, Singh R, Medeiros LJ, Kantarjian HM, Luthra R, Wang SA. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. J Hematol Oncol 8:45, 2015. e-Pub 2015. PMID: 25952993.
192. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 8:32, 2015. e-Pub 2015. PMID: 25888368.
193. Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Fu B, Tang G, Goswami M, Singh R, Kanagal-Shamanna R, Pierce SA, Young KH, Kantarjian HM, Medeiros LJ, Luthra R, Wang SA. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leuk Res 39(3):348-54, 2015. e-Pub 2015. PMID: 25573287.
194. Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, Goswami M, Yin CC, Lu G, Medeiros LJ, Tang G. Isolated +15 in bone marrow: disease-associated or a benign finding?. Leuk Res 39(1):72-6, 2015. e-Pub 2015. PMID: 25435027.
195. Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, Muzzafar T, Medeiros LJ, Wang SA, Bueso-Ramos CE. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol 46(1):65-73, 2015. e-Pub 2015. PMID: 25387813.
196. Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, Bueso-Ramos CE, Jorgensen JL, Lin P, Medeiros LJ, Lu X. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis. Pediatr Hematol Oncol 32(8):535-47, 2015. e-Pub 2015. PMID: 26558423.
197. Gu J, Patel KP, Bai B, Liu CH, Tang G, Kantarjian HM, Tang Z, Abraham R, Luthra R, Medeiros LJ, Lin P, Lu X. Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression. Mol Cytogenet 8:68, 2015. e-Pub 2015. PMID: 26300976.
198. Tang G, Wang SA, Lu V, Lee HC, Qazilbash MH, Wang XI, Yin CC, Orlowski R, Wang Y, Patel A, Medeiros LJ, Lu G. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leuk Res 38(8):896-900, 2014. e-Pub 2014. PMID: 24939217.
199. Tang G, Zhang L, Fu B, Hu J, Lu X, Hu S, Patel A, Goswami M, Khoury JD, Garcia-Manero G, Medeiros LJ, Wang SA. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution. Am J Hematol 89(8):813-8, 2014. e-Pub 2014. PMID: 24782398.
200. Tang G, Banks HE, Sargent RL, Medeiros LJ, Abruzzo LV. Chronic lymphocytic leukemia with t(14;18)(q32;q21). Hum Pathol 44(4):598-605, 2013. e-Pub 2013. PMID: 23084581.
201. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PM, Huh YO, Jones DM, Bueso-Ramos C, Verstovsek S, Medeiros LJ, Miranda RN. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol 88(3):219-24, 2013. e-Pub 2013. PMID: 23440662.
202. Liu D, Lin P, Hu Y, Zhou Y, Tang G, Powers L, Medeiros LJ, Jorgensen JL, Wang SA. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma. J Clin Pathol 65(9):823-9, 2012. e-Pub 2012. PMID: 22685235.
203. Tang G, Jorgensen LJ, Zhou Y, Hu Y, Kersh M, Garcia-Manero G, Medeiros LJ, Wang SA. Multi-color CD34 progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia. Leuk Res 36(8):974-81, 2012. e-Pub 2012. PMID: 22626984.
204. Tang G, Zuo Z, Thomas DA, Lin P, Liu D, Hu Y, Kantarjian HM, Bueso-Ramos C, Medeiros LJ, Wang SA. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?. Haematologica 97(6):919-25, 2012. e-Pub 2012. PMID: 22207681.
205. Zhou Y, Tang G, Medeiros LJ, McDonnell TJ, Keating MJ, Wierda WG, Wang SA. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Mod Pathol 25(2):237-45, 2012. e-Pub 2012. PMID: 22080061.
206. Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leuk Res 35(6):766-70, 2011. e-Pub 2011. PMID: 21367453.
207. Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang SA. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 115(10):1985-92, 2010. e-Pub 2010. PMID: 20040759.
208. Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer 113(12):3331-40, 2008. e-Pub 2008. PMID: 18988232.
209. Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol 21(11):1394-402, 2008. e-Pub 2008. PMID: 18839018.
210. Tang G, Truong F, Fadare O, Woda B, Wang SA. Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts. Int J Clin Exp Pathol 1(6):544-9, 2008. e-Pub 2008. PMID: 18787634.
211. Tang F, Tang G, Xiang J, Dai Q, Rosner MR, Lin A. The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 22(24):8571-9, 2002. e-Pub 2002. PMID: 12446776.
212. Tang G, Yang J, Minemoto Y, Lin A. Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell 8(5):1005-16, 2001. e-Pub 2001. PMID: 11741536.
213. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature 414(6861):313-7, 2001. e-Pub 2001. PMID: 11713531.
214. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98(12):6668-73, 2001. e-Pub 2001. PMID: 11381115.
215. Roy-Chowdhuri S, Diks JEB, Tang Z, Altan M, Anderson SE, Chen H, Rashid A, Yang R, Routbort MJ, Patel KP, Toruner GA, Medeiros LJ, Tang G, Luthra R. Detection of Clinically Actionable Gene Fusions by Next-Generation Sequencing-Based RNA Sequencing of Non-Small Cell Lung Cancer Cytology Specimens: A Single Center Experience with Comparison to Fluorescence in Situ Hybridization. Cancer Cytopathology.

Invited Articles

1. Stone M, Lilley CM, Tang G, Loghavi S, Mirza KM. Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review. Cytopathology 34(6):530-541, 2023. e-Pub 2023. PMID: 37522274.
2. Tang G, Medeiros LJ, Wang SA. How I investigate Clonal cytogenetic abnormalities of undetermined significance. Int J Lab Hematol 40(4):385-391, 2018. e-Pub 2018. PMID: 2962489.

Other Articles

1. Sameeta F, Fang H, Wang W, Tang Z, Wang SA, Toruner GA, Parisi X, Khoury JD, Issa G, Garcia-Manero G, Medeiros LJ, Tang G, Loghavi S Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma. Am J Hematol 99(9):1827-1829, 2024. PMID: 38440855.
2. E S, Tang G, Li S, Schlette E, Wang SA, Xu J Anaplastic large cell lymphoma with ATIC::ALK in leukemic phase and associated with hemophagocytic lymphohistiocytosis. Int J Lab Hematol. PMID: 39109887.
3. Hu S, Jabbour EJ, Hu CY, Tang G, Wang W, Medeiros LJ, Bueso-Ramos C Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive?B-ALL and pose a diagnostic challenge. Am J Hematol 99(4):721-726, 2024. PMID: 38240333.
4. Rivera D, Cui W, Gao J, Peker D, Zhang QY, Dewar R, Qiu L, Konoplev S, Hu Z, Sasaki K, Hu AY, E S, Liu M, Fang H, Wang W, Tang G, Apperley JF, Hochhaus A, Cortes JE, Khoury JD, Medeiros LJ, Jabbour E, Hu S Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group. Mod Pathol 37(2):100406, 2024. PMID: 38104892.
5. Quesada AE, Hu S, Li S, Toruner GA, Wei Q, Loghavi S, Ok CY, Jain P, Thakral B, Nwogbo OV, Kim D, Iyer SP, You MJ, Medeiros LJ, Tang G Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma. Hum Pathol 144:71-76, 2024. PMID: 38301962.
6. Vanjari N, Tang G, Toruner GA, Wang W, Thakral B, Zhao M, Dave BJ, Khoury JD, Medeiros LJ, Tang Z Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal Aberrations: A Case Report and Literature Review. Genes (Basel) 14(12), 2023. PMID: 38137010.
7. Jelloul FZ, Quesada AE, Yang RK, Li S, Wang W, Xu J, Tang G, Yin CC, Fang H, El Hussein S, Khoury J, Bassett RL, Garcia-Manero G, Manasanch EE, Orlowski RZ, Qazilbash MH, Patel KP, Medeiros LJ, Lin P Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies. Mod Pathol 36(6):100166, 2023. PMID: 36990279.
8. Zhang L, Shah B, Zhang Y, Tashkandi H, Xiao W, Fernandez-Pol S, Vergara-Lluri M, Hussaini M, Song J, Lancet J, Moscinski L, Yun S, Lu CM, Medeiros LJ, Tang G Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review. Hum Pathol 136:1-15, 2023. PMID: 36958463.
9. Garces S, Rudzki Z, Yin CC, Miranda RN, Medina AM, Sriganeshan V, Cuglievan B, Li S, Xu J, Jelloul F, Khoury JD, Thakral B, Tang G, Garces JC, Medeiros LJ MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential Diagnosis. Am J Surg Pathol 46(11):1514-1523, 2022. PMID: 35877199.
10. Ghosh A, Marques-Piubelli ML, Wang X, Sheu TG, Cheng J, Khan K, Lu W, Manning J, Tang G, Solis LM, Vega F CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma. Virchows Arch 481(4):659-663, 2022. PMID: 35622145.
11. Fang H, Toruner GA, Tang Z, Tang G, Weissferdt A, Tashakori M, El Hussein S, Thakral B, Quesada AE, Wang W, Patel KP, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE, Jelloul FZ Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and TP53 mutation: A report of two cases. Ann Diagn Pathol 59:151951, 2022. PMID: 35489185.
12. Wang L, Wang W, Beird HC, Cheng X, Fang H, Tang G, Toruner GA, Yin CC, You MJ, Issa GC, Borthakur G, Peng G, Khoury JD, Medeiros LJ, Tang Z PPP1R7 Is a Novel Translocation Partner of CBFB via t(2;16)(q37;q22) in Acute Myeloid Leukemia. Genes (Basel) 13(8), 2022. PMID: 36011278.
13. Qiu L, Nunez CA, Tang G, Cuglievan B, Issa GC, Wang SA, Medeiros LJ, Thakral B A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion. Ann Hematol 101(7):1579-1581, 2022. PMID: 35091795.
14. Xie W, Medeiros LJ, Li S, Tang G, Fan G, Xu J PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas. Biomedicines 10(7), 2022. PMID: 35884893.
15. Jain P, Han X, Wang M, Tang G Smudge cells in CD200+, TP53 mutated leukemic mantle cell lymphoma. Blood Res 57(2):85, 2022. PMID: 35551107.
16. Young PE, Kanagal-Shamanna R, Hu S, Tang G, Thakral B, Daver N, Issa GC, Medeiros LJ, Konoplev S Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institution. Leuk Res 111:106685, 2021. PMID: 34438119.
17. Thakral B, Jain N, Tang G, Konoplev S, Vega F, Medeiros LJ, Wang SA From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia. Ann Diagn Pathol 53:151767, 2021. PMID: 34118580.
18. Khanlari M, Wang SA, Fowler NH, Tang G, Saluja K, Muzzafar T, Medeiros LJ, Thakral B Concurrent TP53 Mutation and Deletion in Refractory Low-grade Follicular Lymphoma. Clin Lymphoma Myeloma Leuk 21(7):e626-e629, 2021. PMID: 33867306.
19. Tashakori M, Thakral B, Tang G, Khoury JD, Medeiros LJ From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature. Ann Diagn Pathol 52:151720, 2021. PMID: 33676171.
20. Larson DP, Akkari YM, Van Dyke DL, Raca G, Gardner JA, Rehder CW, Kaiser-Rogers KA, Eagle P, Yuhas JA, Gu J, Toydemir RM, Kearney H, Conlin LK, Tang G, Dolan MM, Ketterling RP, Peterson JF Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. Arch Pathol Lab Med 145(2):176-190, 2021. PMID: 32886736.
21. Wilson NR, Fang H, Loghavi S, Wang W, Tang G, Haltom RO, Rausch CR, McClain KL, Rao KV, Popat UR, Fayad LE, Champa N, Calvo KR, Allen CE, Kadia TM, Pemmaraju N Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol 192(3):667-671, 2021. PMID: 33238033.
22. Jain P, Tang G, Li S, Wang M "Triple hit" SOX11- , MME+ , TP53 mutated high-grade pleomorphic mantle cell lymphoma. Am J Hematol 96(1):165-166, 2021. PMID: 32356355.
23. Khanlari M, Tang G, Hao S, Gong Y, Li S, Miranda RN, Lin P, Iyer S, Yin CC, Xie W, Vega F, Medeiros LJ, Xu J Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192(1):e17-e21, 2021. PMID: 33216956.
24. Luo S, Tang G, Zhang G A rare case of infantile desmoid-type fibromatosis on the thigh. Indian J Dermatol Venereol Leprol 87(4):601, 2021. PMID: 34160165.
25. Shao H, Wang W, Song J, Tang G, Zhang X, Tang Z, Srivastava J, Shah B, Medeiros LJ, Zhang L Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement. Leuk Res 99:106460, 2020. PMID: 33166908.
26. Luo DX, Li W, Ye MT, Yang Y, Tang G, You MJ "Double hit" anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements. Am J Hematol 95(12):1625-1627, 2020. PMID: 32833271.
27. Wang W, Beird H, Kroll CJ, Hu S, Bueso-Ramos CE, Fang H, Tang G, Tang Z, Wang F, Takahashi K, You MJ, Khoury JD, Medeiros LJ, Futreal PA T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid. Leukemia 34(9):2509-2512, 2020. PMID: 32099038.
28. Liu W, Thakral B, Tang G, Wang W, Medeiros LJ, Konoplev S From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH/EPOR fusion. Ann Diagn Pathol 46:151514, 2020. PMID: 32330662.
29. Xie W, Tang G, Wang E, Kim Y, Cloe A, Shen Q, Zhou Y, Garcia-Manero G, Loghavi S, Hu AY, Wang S, Bueso-Ramos CE, Kantarjian HM, Medeiros LJ, Hu S t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?. Ann Hematol 99(3):487-500, 2020. PMID: 32006151.
30. Zhang Z, Jiang M, Borthakur G, Luan S, Huang X, Tang G, Xu Q, Ji D, Boyer AD, Li F, Huang R, You MJ Acute myeloid leukemia with a novel CPSF6-RARG variant is sensitive to homoharringtonine and cytarabine chemotherapy. Am J Hematol 95(2):E48-E51, 2020. PMID: 31769058.
31. Crespo J, Sun H, Wu J, Ding QQ, Tang G, Robinson MK, Chen H, Sahin AA, Lim B Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy. PLoS One 15(11):e0241775, 2020. PMID: 33180796.
32. Alotaibi AS, Yilmaz M, Loghavi S, DiNardo C, Borthakur G, Kadia TM, Thakral B, Pemmaraju N, Issa GC, Konopleva M, Short NJ, Patel K, Tang G, Ravandi F, Daver N Emergence of BCR-ABL1 Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case Series. Front Oncol 10:588876, 2020. PMID: 33194747.
33. Salehi S, Astle JM, Sadigh S, Lake J, Aikawa V, Tang G, Wang SA, Bagg A Myeloid neoplasm with eosinophilia and PCM1-JAK2 associated with acute promyelocytic leukemia with PML-RARA. Leuk Lymphoma 60(9):2299-2303, 2019. PMID: 30806106.
34. Tang Z, Wang L, Tang G, Medeiros LJ Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects. Int J Mol Sci 20(16), 2019. PMID: 31412611.
35. Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Exp Mol Pathol 108:131-136, 2019. PMID: 31004601.
36. Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Am J Dermatopathol 41(3):167-179, 2019. PMID: 30801340.
37. Sakhdari A, Tang G, Ginsberg LE, Hirsch-Ginsberg CF, Bueso-Ramos CE, Medeiros LJ, Miranda RN Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy. Case Rep Pathol 2019:4915086, 2019. PMID: 30941227.
38. Swaminathan M, Patel KP, Huynh-Lu J, Tang G, Zuo Z, Miranda R, Verstovsek S Unique Case of Myeloproliferative Neoplasm with Two Rare Clonal Abnormalities: Rare JAK2 Exon 12 Mutation and Rare e14a3 (b3a3) BCR/ABL Fusion Transcript. Acta Haematol 141(1):23-27, 2019. PMID: 30463063.
39. Xie W, Wang SA, Hu S, Xu J, Medeiros LJ, Tang G Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors. Cancer Genet 228-229:41-46, 2018. PMID: 30553471.
40. Verstovsek S, Subbiah V, Masarova L, Yin CC, Tang G, Manshouri T, Asatiani E, Daver NG Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol 29(8):1880-1882, 2018. PMID: 29767670.
41. Zhou Y, Kanagal-Shamanna R, Zuo Z, Tang G, Medeiros LJ, Bueso-Ramos CE Advances in B-lymphoblastic leukemia: cytogenetic and genomic lesions. Ann Diagn Pathol 23:43-50, 2016. PMID: 27130145.
42. Jain P, Tang G, Konoplev SN, Kanagal-Shamanna R, Wang SA, Pemmaraju N, Daver N, Estrov Z Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations. Am J Hematol 91(3):354-5, 2016. PMID: 26437693.
43. Liu H, Wang W, Tang G, Yin CC, Muzzafar T, Medeiros LJ, Hu S Lymphomatous variant of hairy cell leukaemia: a distinctive presentation mimicking low-grade B-cell lymphoma. Histopathology 67(5):740-5, 2015. PMID: 25809821.
44. Chen Z, Wang W, Rich A, Tang G, Hu S Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases. Am J Hematol 90(8):E146-8, 2015. PMID: 25960187.
45. DiNardo CD, Tang G, Pemmaraju N, Wang SA, Pike A, Garcia-Manero G, Cortes J, Bueso-Ramos C, Kantarjian HM Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation. Clin Lymphoma Myeloma Leuk 15(1):47-51, 2015. PMID: 25081372.
46. Tang G, Lu X, Wang SA, Roney EK, Zhang L, Hu S, Lu G, Medeiros LJ, Patel A Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms. Int J Clin Exp Pathol 7(6):3196-201, 2014. PMID: 25031740.
47. Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol 40(8):1194-9, 2009. PMID: 19427022.
48. Arendt CW, Tang G, Zilberstein A Vector systems for the delivery of small interfering RNAs: managing the RISC. Chembiochem 4(11):1129-36, 2003. PMID: 14613103.

Abstracts

1. Toruner G, Tang Z, Kanagal-Shamanna R, Medeiros LJ, Tang G. Clinical Utility of Optical Genome Mapping: Comparison with Standard Cytogenomics Work-up for Hematological Malignancies. Cancer Genetics, 2023. e-Pub 2023.
2. Tang G, Tang Z, Kanagal-Shamanna R, Kantarjian H, Garcia-Manero G, Cuglievan B, McCall D, Robinson M, Reynolds A, Danos C, Cardona G, Geiger C, Yang S, Medeiros LJ, Jain P, Toruner G. Optical Genome Mapping for Cytogenomic Analysis of Hematological Neoplasms. 2023 ASCO Annual meeting, Chicago. Journal of Clinical Oncology 16_suppl e19016, 2023. e-Pub 2023.
3. Liu M, Wang X, E S, Tang G, Wang W, Jelloul F, Lin P, Medeiros LJ, Hu S. Myeloid Neoplasms with t(2;3)(p21~23;3q26.2): a Report of 21 Cases. Laboratory Investigation 103(3 Suppl):S1184, 2023. e-Pub 2023.
4. Nirmalanantham P, Hu S, Li S, Xu J, Tang G, Lin P. Deletion of CDKN2C is frequently associated with gains or amplifications of CKS1B and deletion of TP53 and a complex karyotype. Laboratory Investigation 103(3 Suppl):S1213, 2023. e-Pub 2023.
5. Nahmod K, Tang Z, Lin P, Toruner GA, Li S, Xu J, Hu S, Medeiros LJ, Tang G. Cytogenetic Clonal Evolution in Plasma Cell Neoplasms. Laboratory Investigation 103(3 Suppl):S1208, 2023. e-Pub 2023.
6. Nahmod K, Thakral B, Wang W, Aakash F, Patel KP, Routbort MJ, Kanagal-Shamanna R, Ok CY, Tang G, Vega F, Medeiros LJ, Wang SA, Loghavi S. Bone Marrow Immunophenotype and Genotype Characteristics Assessed by Flow Cytometry and Next Generation Sequencing in 147 Patients with Myeloid Sarcoma. Laboratory Investigation 103(3 Suppl):S1206, 2023. e-Pub 2023.
7. E S, Liu M, Fang H, Wang W, Tang G, Medeiros LJ, Hu S. Immunophenotypic Landscape and Prognosis of Patients with Blast Phase of Chronic Myeloid Leukemia in the Last Decade: A study of 236 cases. Laboratory Investigation 103(3 Suppl):S1126, 2023. e-Pub 2023.
8. Nahmod K, Wang SA, Li S, Tang Z, Xu J, Hu S, Medeiros LJ, Tang G. Immunophenotype and Cytogenetic Abnormalities in Plasma Cells of Lymphoplasmacytic Lymphoma and their Roles in Differential Diagnosis. Laboratory Investigation 103(3 Suppl):S1209, 2023. e-Pub 2023.
9. Diks J, Tang Z, Altan M, Chen H, Rashid A, Yang R, Routbort M, Patel KP, Toruner GA, Tang G, Roy-Chowdhuri S. Clinically Actionable Gene Fusion Detection by Next-Generation Sequencing-Based RNA Sequencing in Non-Small Cell Lung Cancer Cytology Specimens: A Single Center Experience with Comparison to Fluorescence in Situ Hybridization. Laboratory Investigation 103(3 Suppl), 2023. e-Pub 2023.
10. E S, Medeiros LJ, Li S, Wang SA, Lin P, Wand W, Iyer SP, Malpica-Castillo L, Yin CC, Tang G, Tang Z, You MJ, Xu J. Low CD25 Expression is Associated with Older Age and Poorer Prognosis in Patients with ALK+ Anaplastic Large Cell Lymphoma. USCAP 03/2023. Laboratory Investigation. Laboratory Investigation 103(3 Suppl):S1127, 2023. e-Pub 2023.
11. Kim DH, Tang G, Lin P, Xu J, Wang SA, Qiu L, Yin CC, Wang W, Medeiros LJ, Li S. MYC and BCL6 Double Hit Lymphoma (DHL): A Clinicopathologic Study of 60 Cases in Comparison to BCL2-DHL and Diffuse Large B-cell Lymphoma (DLBCL). Laboratory Investigation 103(3 Suppl):S1166, 2023. e-Pub 2023.
12. Fisher-Campbell N, Hoyos CM, Traer E, Gandhi A, Swords R, Li P, Wang S, Tang G, Wang W, Wiszniewska J, Dunlap J, Raess P, Williams T, Press RD, Fan G, Xie W. Clinicopathologic Features of Patients with PPM1D Mutations: Myeloid Neoplasm Post Cytotoxic Therapy and De Novo Myeloid Neoplasms. Laboratory Investigation 103(3 Suppl):S1134, 2023. e-Pub 2023.
13. Streich L, Fisher-Campbell N, Hoyos CM, Traer E, Gandhi A, Swords R, Li P, Wang S, Tang G, Wang W, Wiszniewska J, Dunlap J, Raess P, Williams T, Press RD, Fan G, Xie W. PPM1D Mutations in Patients with Hematolymphoid Neoplasms. Laboratory Investigation 103(3 Suppl):S1244, 2023. e-Pub 2023.
14. Tang Z, Tang G, Toruner GA, Yang S, Wang W, Fang H, El Achi H, Thakral B, Xu J, Yin CC, You J, Miranda R, Khoury JD, Medeiros LJ. Acquired 3q26.2 Aberrations/MECOM Rearrangements Are Common in Donor Cell Leukemia. Laboratory Investigation 103(3 Suppl):S1249, 2023. e-Pub 2023.
15. Toomer KH, Tang G, Cheng J, Gong Y, Mamie Lih TS, Zhang H, Zhang B, Chan DW, Li QK. Correlation between HER2 Immunohistochemistry (IHC) Staining Pattern and HER2/neu Copy-Number Amplification in Primary and Metastatic Non-Small Cell Lung Carcinoma (NSCLC): A Study of 232 Cases. Laboratory Investigation 103(3 Suppl), 2023. e-Pub 2023.
16. Jain P, Ok CY, Fetooh A, Kanagal-Shamanna R, Jelloul FZ, Hill H, Floyd K, Loghavi S, Zuo Z, Yin CC, Routbort M, Tang G, Ahmed S, Malpica Castillo LE, Siddiqui A, Chen W, Oriabure O, Badillo M, Steiner RE, Iyer SP, Lee HJ, Luthra R, Vega F, Flowers CP, Medeiros LJ, Wang M, Patel KP, Fowler NH, Nair R. Mutation Spectrum, Characteristics and Impact of Mutation Profiling on Prognosis, Outcome and Treatment Responses in Patients (pts) with Mantle Cell Lymphoma. Blood 140 (Suppl 1):3598-3600, 2022. e-Pub 2022.
17. Pasvolsky O, Milton DR, Rauf M, Ghanem S, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour SA, Saini N, Lin P, Ramdial JL, Nieto Y, Tang G, Lee HC, Patel K, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Rezvani K, Shpall EJ, Champlin RE, Lin P, Qazilbash MH. Impact of Presence and Amount of Clonal Plasma Cells in Autografts Affect Outcomes in High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant. Blood 140 (Suppl 1):284-286, 2022. e-Pub 2022.
18. Qiu L, Tang G, Li S, Lin P, Wang S, Konoplev S, Miranda RN, Iyer SP, Wang W, Xu J. DUSP22-Rearrangement is Associated with Younger Age, Unique Immunophenotype, and Minimal expression of PD-L1 and pSTAT3, but not Prognosis in Patients with Systemic ALK-Negative Anaplastic Large Cell Lymphoma. Modern Pathology 35 (Suppl 2):1004 (#932), 2022. e-Pub 2022.
19. Huante EA, Jabbour E, Konopleva M, Nunez C, Konoplev S, Short N, Pemmaraju N, Jelloul FZ, Tang G, Kantarjian H, Jain N. Outcomes of Patients with B-ALL with Concomitant BCR::ABL1 and CRLF2 Rearrangements. Blood 140 (Suppl 1):3178-80, 2022. e-Pub 2022.
20. Wang X, Fang H, Kanagal-Shamanna R, Tang G, Wang W, Xu J, Jabbour EJ, Jain N, Jorgensen J, Medeiros LJ, Wang SA, Konoplev S. CD10-/CD15+/CD34- Immunophenotype Does Not Predict KMT2A Rearrangement in Adults with B-Lymphoblastic Leukemia/Lymphoma (B-LBL). Modern Pathology 35 (Suppl 2):1034 (#957), 2022. e-Pub 2022.
21. Nwogbo OV, Hao S, Hu S, Li S, Xu J, Yin C, Bueso-Ramos C, Tang G, Medeiros LJ, Lin P. Prognostic impact of 8q24/MYC gene rearrangement in myeloma in the era of novel therapy. Modern Pathology 35 (Suppl):997 (#923), 2022. e-Pub 2022.
22. Loghavi S, Reville PK, Lachowiez CA, Routbort M, Patel K, Kanagal-Shamanna R, Ok CY, Khoury JD, Tang G, Wang SA, Kadia TM, Daver N, Takahashi K, Garcia-Manero G, Pierce SA, Konopleva M, Medeiros LJ, Kantarjian H, Ravandi F, Short N, DiNardo CD. The Adverse Effect of Myelodysplasia-Related Mutations in De Novo Acute Myeloid Leukemia Is Associated with Higher Variant Allelic Frequency (VAF): A Proposal for a Numeric Cutoff for Variant Allelic Frequency. Blood 140 (Suppl 1):6306-8, 2022. e-Pub 2022.
23. Qiu L, Khanlari M, Tang G, Xu J, Lin P, Khoury JD, Konoplev S, Garces S, Wang S, Wang W, Medeiros LJ, Li S. Clinicopathologic and Cytogenetic Features of Blastoid High-grade B-cell Lymphoma. Modern Pathology 35 (Suppl 2):1003-4 (#931), 2022. e-Pub 2022.
24. Tang Z, Wang W, Toruner GA, Yang S, Fang H, Xu J, Thakral B, Zhao M, Ayoub E, Issa GC, Yin CC, You MJ, Khoury JD, Medeiros LJ, Tang G. MECOM Rearrangement by Pericentric Inversion 3 Presents a Diagnostic Challenge. Cancer Genetics 268-269 (Suppl 1), 2022. e-Pub 2022.
25. Daver N, Senapati J, Maiti A, Loghavi S, Kadia TM, DiNardo CD, Pemmaraju N, Jabbour E, Montalban-Bravo G, Tang G, Sasaki K, Borthakur G, Yilmaz M, Alvarez J, Pierce SA, Nogueras González GM, Ning J, Issa GC, Andreeff M, Abbas HA, Ravandi HA, Garcia-Manero G, Kantarjian H. Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML. Blood 140 (Suppl 1):141-144, 2022. e-Pub 2022.
26. Wang B, Jelloul FZ, Borges P, Desai P, Tang G, Konopleva M, Baran N, Green MR, Deng Q, Daver N, Futreal A, Hao D, Abbas HA. Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients. Blood 140 (Suppl 1):6272-23, 2022. e-Pub 2022.
27. Qiu L, Khanlari M, Li S, Tang G, Yin CC, Wang SA, Iyer S, M You MJ, Konoplev SN, Miranda RN, Medeiros LJ, and Xu J. Leukemic ALK-negative ALCL is Characterized by Thrombocytopenia, Bone Marrow Involvement, CD7 Positivity, Complex Karyotype, and a Poor Prognosis. Modern Pathology 34 (Suppl):883-884 (#731), 2021. e-Pub 2021.
28. Tang Z, Yin W, Hong L, Vokes N, Tang G, Toruner GA, Chen H, Chowdhuri SR, Zhang J, Medeiros LJ. Clinical Implication of Persistent Positive ALK Status in Lung Cancer: Analysis of 18 cases. Journal of Molecular Diagnostics 23 (Suppl), 2021. e-Pub 2021.
29. Cherng HJ, Khwaja R, Kanagal-Shamanna R, Burger JA, Thompson PA, Ferrajoli A, Estrov Z, Sasaki K, Sampath D, Tang G, Wang X, Kantarjian H, Keating MJ, Wierda WG, Jain N. Retrospective Single-Institution Analysis of Patients with Chronic Lymphocytic Leukemia with TP53 alterations Treated First-Line with Bruton's Tyrosine Kinase Inhibitor-Based Therapy. Blood 138 (Suppl 1):394, 2021. e-Pub 2021.
30. Wang M, Jain P, Lee HJ, Ok CY, Hill H, Navsaria L, Kanagal-Shamanna R, Malpica-Castillo L, Nair R, Iyer SP, Samaniego F, Chen W, Oriabure O, Feng L, Thirumurthi S, Santos D, Tang G, Vega F, Li S, Avellaneda M, Badillo M, Flowers CR. Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial. Blood 138 (Suppl 1):3525, 2021. e-Pub 2021.
31. Jelloul FJ, Yang R, Li S, Tang G, Patel K, Medeiros LJ, Lin P. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Myeloma Patients in The Era of Novel Therapies: A Study of 60 Patients. Modern Pathology 34 (Suppl):847-48 (#705), 2021. e-Pub 2021.
32. Konoplev S, Tang G, Pozdnyakova O, Wang X, Wang W, Thakral B, Xu J, Pierce SA, Jia F, Jorgensen JL, Ravandi F, Issa GC, Medeiros LJ, Wang SA, and Robert Hasserjian RP. Oligoblastic (<20%) Myeloid Neoplasms with KMT2A (MLL) Rearrangement Show Significant Overlap with Acute Myeloid Leukemia and Should Be Regarded as AML. Blood 138 (Suppl 1):793, 2021. e-Pub 2021.
33. Venugopal S, Issa GC, Konopleva M, DiNardo CD, Borthakur G, Jabbour EJ, Pemmaraju N, Yilmaz M, Short NJ, Maiti A, Sasaki K, Masarova L, Pierce SA, Takahashi K, Tang G, Loghavi S, Andreeff M, Bhalla KN, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N. NPM1 Mutations Do Not Retain a Favorable Prognostic Impact in Adults with Advanced Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML). Blood 138 (Suppl 1):2287, 2021. e-Pub 2021.
34. Khanlari M, Lin P, Xu J, You MJ, Tang G, Yin CC, Qiu L, Bueso-Ramos C, Medeiros LJ, Li S. Blastoid B-cell Lymphoma Initially Presenting in Bone Marrow: A Diagnostic Challenge. Modern Pathology 34 (Suppl):865-866 (#718), 2021. e-Pub 2021.
35. Tang Z, Chen H, Jung HS, Tang G, Toruner G, Gu, J, Khoury JD, Medeiros LJ. ALK tissue FISH in lung cancer: The MDACC experience. Cancer Genetics S17:252-253, 2021. e-Pub 2021.
36. Tang G, Toruner G, Tang Z. Optical Genome Mapping Reveals Genomic Complexity and Detects Novel Genetic Abnormalities in T-Lymphoblastic Leukemia. Cancer Genetics 260-261 (Suppl):19, 2021. e-Pub 2021.
37. Wang X, Tang G, Hu Z, Wang W, Toruner, GA, Tang Z, Bueso-Ramos CE, Medeiros LJ, Hu S. Acute myeloid leukemia and myelodysplastic syndrome with MYC rearrangement. Modern Pathology 34 (Suppl):903-904 (#747), 2021. e-Pub 2021.
38. Daver N, Konopleva M, Maiti A, Kadia TM, DiNardo CD, Loghavi S, Pemmaraju N, Jabbour EJ, Montalban-Bravo G, Tang G, Sasaki K, Borthakur G, Yilmaz M, Alvarez J, Golez M, Pierce SA, González GM, Ning J, Abbas HA, Ravandi F, Garcia-Manero G, Kantarjian H. Quizartinib (Quiz) with Decitabine (DAC) and Venetoclax (VEN) Is Highly Active in Patients (pts) with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) - RAS/MAPK Mutations Continue to Drive Primary and Secondary Resistance. Blood 138 (Suppl 1):371, 2021. e-Pub 2021.
39. Yilmaz M, Kantarjian H, Short NJ, Konopleva M, Kadia TM, DiNardo CD, Borthakur G, Pemmaraju N, Maiti A, Jabbour EJ, Issa GC, Jain N, Takahashi K, Sasaki K, Ohanian M, Tang G, Loghavi S, Patel K, Garcia-Manero G, Andreeff M, Ravandi F, Daver N. Hypomethylating Agent (HMA) Therapy and Venetoclax (VEN) with FLT3 Inhibitor "Triplet" Therapy Is Highly Active in Older/Unfit Patients with FLT3 Mutated AML. Blood 138 (Suppl 1):798, 2021. e-Pub 2021.
40. Liu W, Xu J, Medeiros LJ, Tang G. LPL deletion: a potential biomarker to further stratify 17p-deleted chronic lymphocytic leukemia patients. Modern Pathology 33 (Suppl 2):1336-1337 (#1419), 2020. e-Pub 2020.
41. Jain P, Zhang S, Kanagal-Shamanna R, Navsaria L, Ok CY, Tang G, Yin CC, Badillo M, Chen W, Oriabure O, Lee HJ, Westin J, Nastoupil LJ, Moghrabi O, Che Y, Samaniego F, Ahmed S, Nair R, Li S, Vega F, Flowers C, Wang L, Wang M. Outcomes of Acalabrutinib Failures in Relapsed Mantle Cell Lymphoma. Blood 136 (Suppl 1):9-10, 2020. e-Pub 2020.
42. Wang M, Jain P, Yao Y, Liu Y, Zhao S, Hill H, Moghrabi O, Lee HJ, Samaniego F, Westin J, Nastoupil LJ, Kanagal-Shamanna R, Ok CY, Chen W, Oriabure O, Che Y, Li Y, Feng L, González GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Vega F, Yin CC, Avellaneda M, Badillo M, Flowers C, Wang L. Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hypercvad/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial. Blood 136 (Suppl 1):35-36, 2020. e-Pub 2020.
43. Huang X, Chen H, Ding Q, Robinson M, Bassett R, Tang G, Sahin A. Clinicopathological Features of HER2 Positive Classic Invasive Lobular Carcinoma. Modern Pathology 33 (Suppl 2):180 (#188), 2020. e-Pub 2020.
44. Jain P, Yao Y, Zhao S, Liu Y, Hill H, Che Y, Li Y, Jordan AA, McIntosh J, Lee HJ, Steiner RE, Samaniego F, Westin J, Nastoupil LJ, Nair R, Ahmed S, Ok CY, Kanagal-Shamanna R, Oriabure O, Xu G, Chen W, Moghrabi O, McClain CM, Badillo M, Thirumurthi S, Santos D, Iliescu C, Yin CC, Li S, MD, Tang G, Vega F, Neelapu SS, Flowers C, Wang L, Wang M. Combination of Ibrutinib with Rituximab (IR) in Previously Untreated Older Patients with Mantle Cell Lymphoma (MCL) - a Phase II Clinical Trial. Blood 136 (Suppl 1):41-42, 2020. e-Pub 2020.
45. Fang H, Beird HC, Hu S, Bueso-Ramos C, Tang G, Tang Z, You MJ, Khoury JD, Medeiros LJ, Wang W. t(6;14)(q25;q32) involves BCL11B and is highly associated with mixed phenotype acute leukemia, T/myeloid. Modern Pathology 33 (Suppl 2):1280-81 (#1358), 2020. e-Pub 2020.
46. Jain P, Tang G, Yin CC, Ok CY, Navsaria L, Badillo M, Chen W, Li Y, Chen Y, Liu Y, Oriabure O, González GM, Westin J, Nastoupil LJ, Ahmed S, Nair R, Thirumurthi S, Li S, Kanagal-Shamanna R, Vega F, Flowers C, Wang M. Complex Karyotype Is a Significant Predictor for Worst Outcomes in Patients with Mantle Cell Lymphoma (MCL) Treated with BTK Inhibitors - Comprehensive Analysis of 396 Patients. Blood 136 (Suppl 1):32-33, 2020. e-Pub 2020.
47. Jain P, Kanagal-Shamanna R, Navsaria L, Ok CY, Hill H, Jung D, González GM, Lee HJ, Nair R, Ahmed S, Steiner RE, Tang G, Li S, Patel K, Thirumurthi S, Tinsu P, Xu G, Vega F, Flowers C, Wang M. Comprehensive Analysis of Factors Predictive for Time to Transformation and Risk of Transformation in Patients (pts) with Mantle Cell Lymphoma. Blood 136 (Suppl 1):41-42, 2020. e-Pub 2020.
48. Xie W, Tang G, Wang E, Kim Y, Cloe A, Shen S, Zhou Y, Loghavi S, Wang SA, Bueso-Ramos C, Medeiros LJ, Hu S. t(11;16)(q23;p13) and t(2;11)(p21;q23) in hematologic neoplasms: presumptive evidence of myelodysplasia revisited. Modern Pathology 33 (Suppl 2):1410(#1493), 2020. e-Pub 2020.
49. Tang Z, Tang G, Toruner G, Yin CC, Wang W, Hu S, Zuo Z, Patel K, Khoury JD Medeiros LJ. Atypical CBFB FISH Signal Patterns Warrant Further Investigation for a True CBFB Rearrangement: An Analysis of 2,425 CBFB FISH. Journal of Molecular Diagnostics 22 (Suppl):S22-23, 2020. e-Pub 2020.
50. Toruner G, Tang Z, Tang G, Saglam O. KAT6A Amplification is associated with shorter PFS and OS in serous endometrial carcinoma. Cancer Genetics 244 (Suppl):S22, 2020. e-Pub 2020.
51. Wang ML, Jain P, Lee HJ, Hagemeister FB, Samaniego F, Westin JR, Nastoupil LJ, Chen W, Nomie K, Zhang S, Moghrabi O, Zhao S, Kanagal-Shamanna R, Ok CY, Oriabure O, Nogueras González GM, Jung D, Navsaria L, Uy A, Pedersen A, Zhang L, Jiang C, Lei F, Yao Y, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Patel K, Yin CC, Avellaneda M, Badillo M, Fayad L, Neelapu SS, Fowler NH, Romaguera JE, Wang L. Frontline Treatment with Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hypercvad/MTX Is Extremely Potent and Safe in Patients (age ≤ 65 years) with Mantle Cell Lymphoma (MCL) - Results of Phase-II Window-1 Clinical Trial. Blood 134 (Suppl_1):3987, 2019. e-Pub 2019.
52. Zhou T, Tang G, Loghavi S, Kurt H, Medeiros LJ, Hu S. Significance of idic(X)(q13) in myeloid neoplasms. Modern Pathology 32 (Suppl 2):175-176 (#1432), 2019. e-Pub 2019.
53. Cai T, Black KL, Naqvi AS, Taylor D, Zhao M, Yuan Q, Sugita M, Galetto R, Gouble A, Smith JNP, Cavazos A, Han L, Zhang Q, Kuruvilla VM, Ma H, Konoplev S, Tang G, Gu J, Su X, Neelapu SS, Lane AA, Kantarjian HM, Guzman ML, Pemmaraju N, Thomas-Tikhonenko A, Konopleva M. Efficacy Proof of Concept for Allogeneic CD123 Targeting CAR T-Cells Against Primary Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Efficient Control of Tumor Progression in PDX Model and Potential Loss of CD123 Expression in Relapsed Disease. Blood 134 (Suppl_1):2659, 2019. e-Pub 2019.
54. Ding Q, Sun H, Lim B, Crespo J, Tang G, Robinson M, Sahin A, Chen H. Retrospective Analysis of 158 Breast Cancer Cases of Group 4 HER2 FISH. Modern Pathology 32 (Suppl 2):139-140 (#140), 2019. e-Pub 2019.
55. Jain P, Kanagal-Shamanna R, Ok CY, Omarya G, Navsaria L, Nogueras González GM, Zhang S, Han G, Ghorab A, Boddu P, Hagemeister FB, Lee HJ, Nomie K, Jiang C, Fayad L, Westin JR, Nastoupil LJ, Ahmed S, Iyer SP, Champlin RE, Neelapu SS, Romaguera JE, Fowler NH, Tang G, Li S, Patel K, Thirumurthi S, Tinsu P, Xu G, Wang L, Wang ML. Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma - Cohort Study of 369 Patients. Blood 134 (Suppl_1):1526, 2019. e-Pub 2019.
56. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury JD, Issa GC, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Ohanian M, Borthakur GM, Konopleva MK, Daver N, Estrov Z, Alvarado Y, Ferrajoli A, Kadia TM, Garcia-Manero G, Verstovsek S, Garris R, Cortes JE, O'Brien S, Jabbour E. Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A ( MLL ) Rearrangement. Blood 134 (Suppl_1):2582, 2019. e-Pub 2019.
57. Sakhdari A, Lyapichev K, Medeiros LJ, Tang G. Acute Myeloid Leukemia (AML) with Sole del(11q) Is Associated with Cytopenia, Dysplasia and a Poor Outcome. Modern Pathology 32 (Suppl 2):128 (#1375), 2019. e-Pub 2019.
58. Xie W, Tang G, Zhou T, Xu J, Medeiros LJ, Hu S. Acute Myeloid Leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in Adult Patients. Modern Pathology 32 (Suppl 2):166 (#1419), 2019. e-Pub 2019.
59. Shen J, Li S, Yin CC, Wang SA, Lin P, Jorgensen JL, Tang G, Medeiros LJ, and Xu J. CD8 Expression in Anaplastic Large Cell Lymphoma Identifies a Subgroup with Advanced Stage, Non-common Morphology, Unique Phenotype, and Poorer Outcome. Modern Pathology 32 (Suppl 2):138-139 (#1387), 2019. e-Pub 2019.
60. Hao S, Konoplev S, Lu X, Li S, Hu S, Xu J, Tang G, Mederiois LJ, Lin P. The Survival Impact Of 1q+/CKSB1 Depends On Background Karyotype And Del(17p)/TP53 Allelic Burden. Modern Pathology 32 (Suppl 2):62 (#1300), 2019. e-Pub 2019.
61. Xie W, Wang SA, Chen Z, Li S, Miranda RN, Hu S, Medeiros LJ, Tang G. Myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms followed by acute lymphoblastic leukemia. Modern Pathology 32 (Suppl 2):167 (#1421), 2019. e-Pub 2019.
62. Jain P, Lee HJ, Steiner RC, Hagemeister FB, Samaniego F, Westin JR, Nastoupil LJ, Ahmed S, Iyer SP, Romaguera JE, Zhao S, Nomie K, Ok CY, Kanagal-Shamanna R, Oriabure O, Xu G, Zhang L, Jiang C, Jung D, Navsaria L, Chen W, Moghrabi O, Nizam T, McClain CM, Badillo M, Thirumurthi S, Santos D, Tang G, Patel K, Neelapu SS, Wang L, Fowler NH, Wang ML. . Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial. Blood 134 (Suppl_1):3988, 2019. e-Pub 2019.
63. Sakhdari A, Tang Z, Bueso-Ramos C, Tang G, Medeiros LJ, Huh Y. Homogeneously Staining Region (hsr) on Chromosome 11 Is Highly Specific for KMT2A Amplification in Acute Myeloid Leukemia (AML) and Myelodysplastic syndromes (MDS). Modern Pathology 32 (Suppl 2):129 (#1377), 2019. e-Pub 2019.
64. Jain P, Zhao S, Kanagal-Shamanna R, Navsaria L, Hill H, Misra A, Nomie K, Jiang C, Yao Y, Zhang L, Nastoupil LJ, Hagemeister FB, Westin JR, Nair R, Steiner RE, Oriabure O, Chen W, Tang G, Yin CC, Patel K, Romaguera JE, Fowler NH, Wang L, Wang ML. Non-Bcl2 Mutations Are Predominant in Patients (pts) with Venetoclax Resistant Mantle Cell Lymphoma (MCL) - Response and Clinical Outcomes in Ultra-Refractory MCL. Blood 134 (Suppl_1):2815, 2019. e-Pub 2019.
65. Tang Z, Zhao P, Wang W, Gu J, Patel KP, Ok CY, Toruner GA, Khoury JD, Medeiros LJ, Tang G. Additional Structural Chromosomal Abnormalities Have a Negative Prognostic Effect in Patients with inv(16)/t(16;16) Acute Myeloid Leukemia (AML). Cancer Genetics 233 (Suppl), 2019. e-Pub 2019.
66. Xu J, Wang SA, Wang L, Tang G, Lin P, Yin CC, Medeiros LJ, Li S. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Like Mantle Cell Lymphoma. Modern Pathology 32 (Suppl 2):168 (#1423), 2019. e-Pub 2019.
67. Chen Z, Wang SA, Hu S, Li S, Tang Z, Toruner G, Medeiros LJ, Tang G. Is hyperdiploidy favorable in adult B-lymphoblastic leukemia?. Modern Pathology 32 (Suppl 2):23-24 (#1259), 2019. e-Pub 2019.
68. Toruner G, Tang Z, Tang G, Medeiros LJ, Hu S. Clonal size of ALK rearrangements detected by FISH is associated with the duration of progression free survival in metastatic lung cancer treated with ALK inhibitor. Cancer Genetics 233 (Suppl):S20, 2019. e-Pub 2019.
69. Xie W, Wang J, Chen Z, Tang G, Wang S, Loghavi S, Medeiros LJ, Hu S. Myeloid neoplasm with t(11;16)(q23;p13): a study of 11 cases. Modern Pathology 31 (Suppl 2):565 (#1593), 2018. e-Pub 2018.
70. Chang N, Chen H, Al-Awadhi AM, Tang G, Robinson M, Lim B, Sahin A. Equivocal HER2/neu FISH Results in Breast Cancer: How Frequently Do They Change on Repeat Testing. Modern Pathology 31 (Suppl 2):53 (#155), 2018. e-Pub 2018.
71. Ruiz-Cordero R, Hidalgo-Lopez JE, Bueso-Ramos CE, Routbort M, Kanagal-Shamanna R, Zuo Z, Yin CC, Loghavi Jorgensen JL, Wang S, Tang G, Luthra R, Medeiros LJ, Patel K. Distinct Genetic Features of Myelodysplastic Syndromes as Defined in the Revised 2016 World Health Organization Classification. Modern Pathology 31 (Suppl 2):549 (#1542), 2018. e-Pub 2018.
72. Rahman H, Khoury JD, Bueso-Ramos CE, McDonnell T, Salem A, Wang SA, Muzzafar T, Tetzlaff M, Bell D, Khogeer H, Angelova E, Tang G, Hu S, Patel KP, Routbort M, Luthra R, Lin P, Medeiros LJ, Loghavi S. Aberrant cytokeratin expression in acute myeloid leukemia is associated with complex karyotype and TP53 alteration. Modern Pathology 31 (Suppl 2):546 (#1533), 2018. e-Pub 2018.
73. Aung P, Nagarajan P, Tetzlaff M, Curry J, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto V, Torres-Cabala C. Melanoma with Loss of Bap1 Expression in Patients with No Family History of BAP1-Associated Cancer Susceptibility Syndrome. Modern Pathology 31 (Suppl 2):193 (#528), 2018. e-Pub 2018.
74. Xu J, Saksena A, Wang L, Yin CC, Wang SA, Hu Z, Lin P, Tang G, Medeiros LJ, Li S. Characterization of SOX11-Negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 53 Patients. Modern Pathology 31 (Suppl 2):566 (#1595), 2018. e-Pub 2018.
75. Salem A, Tang G, Loghavi S, Medeiros LJ, Khoury JD. Myeloid Neoplasms with Concurrent BCR-ABL1 and CBFBMYH11 Rearrangements: Clinicopathologic Features and Treatment Implications. Modern Pathology 30 (Suppl 2):374A (#1501), 2017. e-Pub 2017.
76. Hidalgo Lopez JE, Carballo-Zarate A, Medeiros LJ, Bueso-Ramos CE, Tang G. Blast Phase of Polycythemia Vera. Modern Pathology 30 (Suppl 2):361A (#1446), 2017. e-Pub 2017.
77. Liu H, Yin CC, Wang SA, Xu J, Medeiros LJ, Tang G. Clinicopathologic Features of Adult Myeloid Neoplasms Associated with t(16;21). Modern Pathology 30 (Suppl 2):359A (#1441), 2017. e-Pub 2017.
78. Hidalgo Lopez JE, Wang SA, Medeiros LJ, Bueso-Ramos CE, Tang G. Clinical Significance of Cytogenetic Abnormalities in Polycythemia Vera. Modern Pathology 30 (Suppl 2):353A (#1418), 2017. e-Pub 2017.
79. Boddu P, Pemmaraju N, Tang G. MYC Rearrangements in Myeloid Neoplasms. Blood 130 (Suppl 1):1350, 2017. e-Pub 2017.
80. Gur HD, Wang SA, Li S, Medeiros LJ, Tang G. Significance of Isolated Del(7p) in Myeloid Neoplasms. Modern Pathology 30 (Suppl 2), 2017. e-Pub 2017.
81. Hu Z, Wang W, Chen Z, Gong Z, Hodjat P, Bai S, Tang G, Medeiros LJ, Hu S. 3q26.2 rearrangements are associated with a poor prognosis in Ph-negative myeloproliferative neoplasms. Modern Pathology 30 (Suppl 2):355A (#1423), 2017. e-Pub 2017.
82. Gong Z, Tang Z, Chen Z, Wang W, Bai S, Tang G, Medeiros LJ, Hu S. Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia. Modern Pathology 30 (Suppl 2):350A (#1407), 2017. e-Pub 2017.
83. Hu Z, Sun Y, Tang G, Young KH, Medeiros LJ, Jorgensen JL, Wang SA. CD200 Expression in Mantle Cell Lymphoma Correlates with Absence of SOX11 Expression and a Leukemic Presentation. Modern Pathology 30 (Suppl 2):355A (#1422), 2017. e-Pub 2017.
84. Xu J, Saksena A, Zhou J, Li J, Yin CC, Tang G, Medeiros LJ, Li S. CD10-Positive Mantle Cell Lymphoma: Clinicopathologic and Prognostic Study of 28 Cases. Modern Pathology 30 (Suppl 2):387A (#1549), 2017. e-Pub 2017.
85. Sun Y, Tang G, Hu Z, Medeiros LJ, Wang SA. Comparison of TCL1 Overexpression and TCL1 Gene Rearrangement in Patients with T- Cell Prolymphocytic Leukemia. Modern Pathology 30 (Suppl 2):379A (#1521), 2017. e-Pub 2017.
86. Xu J, Saksena A, Desai P, Lin P, Yin CC, Tang G, You MJ, Medeiros LJ, Li S. CD30 expression and its prognostic significance in De Novo diffuse large B cell lymphoma treated with Rituximab-EPOCH. Modern Pathology 29 (Suppl 2):386A (#1525), 2016. e-Pub 2016.
87. Thakral B, Desau P, Lin P, Yin CC, Tang G, Hu S, Khoury JD, Medeiros LJ, Li S. Prognostic significance of CD5 expression in diffuse large B cell lymphoma in patients treated with Rituximab-EPOCH. Modern Pathology 29 (Suppl 2):378A (#1492), 2016. e-Pub 2016.
88. Rogers HJ, His ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JD, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjioan RP. Most myeloid neoplasms with deletion of chromosome 16q are distinct from acute myeloid leukemia with inv(16)(p13.1q22). Modern Pathology 29 (Suppl 2):373A (#1473), 2016. e-Pub 2016.
89. Goswami R, Wang SA, Li Y, Hu S, Medeiros LJ, Tang G. Newly emerged isolated del(7q) may not always be associated with prior cytotoxic therapies. Modern Pathology 29 (Suppl 2):347A (#1377), 2016. e-Pub 2016.
90. Hidalgo López JE, Carballo-Zarate AA, Medeiros LJ, Bueso-Ramos CE, Tang G. Cytogenetic Abnormalities May Predict Transformation to Acute Myeloid Leukemia in Polycythemia Vera Patients. Blood 128(22):2915, 2016. e-Pub 2016.
91. Li Y, Hu S, Wang SA, Huh YO, Li S, Medeiros LJ, Tang G. MYC rearrangement in chronic lymphocytic leukemia, is not often associated with poor prognosis. Modern Pathology 29 (Suppl 2):358A (#1416), 2016. e-Pub 2016.
92. Wang W, Cortes J, Tang G, Khoury JD, Wang S, Bueso-Ramos C, DiGiuseppe JA, Chen Z, Kantarjian H, Medeiros LJ, Hu S. Risk stratification of additional chromosomal changes in chronic myelogenous leukemia in era of tyrosine kinase inhibitor therapy. Modern Pathology 29 (Suppl 2):382A (#1509), 2016. e-Pub 2016.
93. Hu Z, Medeiros LJ, Tang G, Tang Z, Hu S, Lin P, Lu X. Complex karyotype predict a poorer prognosis in T-cell prolymphocytic leukemia. Modern Pathology 29 (Suppl 2):353A (#1395), 2016. e-Pub 2016.
94. Lu X, Reynolds A, Konoplev SN, Wang S, Tang G, Tang Z, Zweidler-McKay, Jorgenson JJ, Patel KP, Medeiros LJ, Lin P, Konoplev M, Jain N. Clinical implementation of a FISH panel and testing algorithm for diagnosis of Ph-like B-cell acute lymphoblastic leukemia. Modern Pathology 29 (Suppl 2):360A (#1424), 2016. e-Pub 2016.
95. Hu Z, Wang W, Chen Z, Tang G, Lu X, Li S, Medeiros LJ, Hu S. Mantle cell lymphoma with MYC rearrangement: best considered as a form of double hit lymphoma. Modern Pathology 29 (Suppl 2):353A (#1396), 2016. e-Pub 2016.
96. Quesada AE, Desai P, Tang G, Lin P, Westin JR, Seegmiller AC, Yin CC, Wang W, Xu J, Miranda RN, Reddy N, Medeiros LJ, Li S. MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma. Blood 128(22):154, 2016. e-Pub 2016.
97. Saksena A, Desai P, Zuo Z, Xu J, Lin P, Seegmiller AS, Yin CC, Tang G, Miranda RN, Jorgensen JL, PhD MD, Nishitha M Reddy NM, Medeiros LJ, Li S. MYC/BCL2 Double Hit Lymphoma: What Really Matters. Blood 126(23):3909, 2015. e-Pub 2015.
98. Shen Q, Li S, Chen M, Song J, Lu G, Tang G, Hu S, Wang XI, Lin P, Medeiros LJ, Yin CC. Acute myeloid leukemia/myelodysplastic syndrome with t(3;5): clinicopathologic, immunophenotypic, and molecular genetic features of 16 cases. Modern Pathology 28 (Suppl 2):337A (#1501), 2015. e-Pub 2015.
99. Tang G, Peng J, Garcia-Manero G, Wang SA. Clonal Cytogenetic Evolution in Chronic Myelomonocytic Leukemia. Modern Pathology 28 (Suppl 2):371A (#1516), 2015. e-Pub 2015.
100. Liu W, Lu G, Liu H, Young KH, Tang G, Fayad L, Medeiros LJ, Hu S. MYC/8q24 deletion in diffuse large B-cell lymphoma. Modern Pathology 28 (Suppl 2):360A (#1437), 2015. e-Pub 2015.
101. Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, Goswami M, Yin CC, Lu G, Medeiros LJ, Tang G. Isolated +15 in bone marrow: disease-associated or a benign finding?. Modern Pathology 28 (Suppl 2):347A (#1387), 2015. e-Pub 2015.
102. Yabe M, Medeiros LJ, Tang G, Wang SA, Konoplev SN, Bueso-Ramos CE, Loghavi S, Lu G, Li S, Young KH, Miranda RN. Prognostic Factors of Hepatosplenic T-Cell Lymphoma (HSTCL): A Clinicopathologic, Immunophenotypic, and Cytogenetic Analysis of 28 Patients. Modern Pathology 28 (Suppl 2):389A (#1550), 2015. e-Pub 2015.
103. Yabe M, Medeiros LJ, Tang G, Wang SA, Konoplev SN, Bueso-Ramos CE, Loghavi S, Lu G, Li S, Young KH, Miranda RN. Evaluation of Myelodysplastic Features and Correlation With Cytogenetic Findings in Hepatosplenic T-Cell Lymphoma: Analysis of 28 Patient. Modern Pathology 28 (Suppl 2):389A (#1549), 2015. e-Pub 2015.
104. Goswami RS, Liang CS, Hu S, Medeiros LJ, Tang G. Isolated del(5q) in patients following therapies for various malignancies, may not all be clinically significant. Modern Pathology 28 (Suppl 2):347A (#1388), 2015. e-Pub 2015.
105. Wang W, Ai A, Tang G, Liu H, Bueso-Ramos CE, Medeiros LJ, Hu S. Balanced 11q23/MLL rearrangement in chronic myelogenous leukemia. Modern Pathology 28 (Suppl 2):384A (#1529), 2015. e-Pub 2015.

Book Chapters

1. Zou Y, Achi HE, Tang G, Phan BH, Phan MH, Anderson TN, Murry JB. Acquired Ring Chromosomes in Tumors of Hematopoietic and Lymphoid Tissues. In: Human Ring Chromosomes: A practical guide for clinicians and families. Springer Nature Switzerland AG, 2023.
2. Khogeer HA, Tang G, Pina-Oviedo S, Miranda RN. Bone marrow pathology. In: Oncological Surgical Pathology. Springer Nature Switzerland AG, 1954 - 2141, 2020.
3. Pina-Oviedo S, Tang G, Khogeer HA, Miranda RN. Lymph node pathology. In: Oncological Surgical Pathology. Springer Nature Switzerland AG, 1729 – 1953, 2020.
4. Su X, Yang X, Tang G. Advanced Clinical Handbook of Infectious Disease. In: Infectious Disease. Hunan Science-Technology Press, 2001.